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Abstract 
Gold Nanoshells for Surface Enhanced Raman Spectroscopy and Drug 
Delivery 
By 
Aoune Barhoumi 
Gold nanoshells are tunable plasmonic nanostructures consisting of spherical silica 
cores wrapped with thin layer of Au. Based on the size of the Au layer with respect to 
the silica core, gold nanoshells can resonantly absorb or scatter light at any wavelength 
on the visible or infrared. On resonance, gold nanoshells interact strongly with light to 
give rise to collective oscillations of the free electrons against the background of the ionic 
core, phenomena known as localized surface plasmons. The free electron oscillation 
creates surface plasmon multimodes of various orders. As a result, the average local near 
field surrounding the Au nanoshell is enhanced. The local field enhancement has been 
extensively used in different applications. In this work, the local near-field is used to 
enhance the Raman spectroscopy of DNA and explore the different modes attributed to 
the base composition and structure of the DNA sequence. We showed that urface 
enhanced Raman spectroscopy of DNA is dominated by the adenine modes regardless of 
the base composition of the DNA sequence, a property that we have used to develop a 
DNA label-free detection system. 
As absorbers, plasmon-resonant Au nanoshells can convert absorbed light into heat. As 
a consequence, the temperature on the Au nanoshell surface increases dramatically. This 
property is used to light-trigger the release of variety of therapeutic molecules such as 
1 
single stranded DNA, siRNA and small molecules. We demonstrated that the local heat 
can be used to dehybridize double stranded DNA attached to the Au surface via a thiol 
moiety on one of the DNA strands. The complementary sequence (therapeutic sequence) 
is released at temperature lower than the standard melting temperature of same DNA 
sequence. Moreover, small molecules (DAPI) which were initially intercalated on the 
double stranded DNA attached to the Au surface were successfully released due to the 
heat generated around the nanoshell surface. Finally, siRNA molecules were also 
released using a different system made of PLL (polylysine) attached to Au nanoshells. 
The electrostatic interaction between the negatively charged siRNA and the positively 
charged PLL was overcome by the thermal perturbation causing the siRNA to be 
released. In vitro experiments successfully showed the release of siRNA, single stranded 
DNA and small molecules. 
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Chapter 1: Introduction 
1.1 Raman Spectroscopy: 
1.1.1 Raman Scattering: 
When electromagnetic (EM) waves interact with a molecule, the electron cloud of the 
molecule oscillates periodically at the same frequency of the incident EM. As a result, an 
induced dipole is created within the molecule. The dipole can radiate light, mostly at the same 
frequency of the emitted light (elastic scattering). However, some of the light is radiated at 
frequencies different than that of the incident light, phenomenon known as non-elastic scattering. 
Raman scattering is an example of the non-elastic scattering of light due to the interaction of 
incident EM with a molecule. 
Classically, Raman scattering can be explained using the model shown in Figure 1.1. The 
molecule is modeled as 2 spheres of masses m1 and m2 connect by a spring of constant k. 
K 
ml m2 V molecule = fi. v;;: 
Figure 1.1: Model of a molecule. The vibrational frequency vis proportional to the square root 
of the force constant and inversely proportional to the reduced mass of the atoms that are bonded 
together 
1 
The incident light 
The induced dipole is f.l = aE (a = polarizability) 
Substituting in the electric field oflight f.l = aE0 cos(mLt) 
Since the polarizability depends on the conformation of the molecule, it will change as the 
molecule vibrates. 
a=a(Q) where Q is the vibrational coordinate 
where Q = Q0 cos(mut) 
The induced dipole can be calculated as: 
The three terms represent frequencies at which light will be emitted. The first emitted frequency 
equals the frequency of the incident light (elastic scattering, example: Rayleigh scattering), the 
second and third emitted frequencies are shifted from the incident light (non-elastic scattering, 
example: Raman scattering). 
da has to be non-zero for Raman scattering to occur. Only molecules that interaction with EM 
dQ 
can induce a change in molecular polarizibilty are Raman active molecules. 
The quantum picture illustrates better the Raman scattering and explains the phenomenon in 
terms of transition between electronic states. When the molecule absorbs the incident light, it 
will be excited from the ground state to a virtual state that is lower than the lowest electronic 
state. The excited electron will return back to the ground state and three cases are possible. Given 
that the ground state has energy sub-levels due to the vibrational states of the molecule, the 
2 
excited electron can return back to the same sub-level giving off the same frequency of the 
incident light in that case the scattering is called Rayleigh scattering. If the electron returns back 
to a different vibrational sub-level (higher or lower in energy than the original sub-level), the 
scattering is called respectively stokes and anti-stokes. 
Electronic 
State 
Virtual 
State 
Ground 
State 
Rayleigh Scattering Stokes Scattering Anti~stokes scattering 
Figure 1.2: Quantum description of the molecular scattering 
As discussed earlier and depicted in the Figure 1.2, the Raman scattering depends on the 
vibrational modes of the molecule. Raman scattering is used as a spectroscopic tool to study 
simple molecules at different phases (especially solid and gas). Raman scattering is used to study 
more complex biological molecules such as DNA and proteins 1• It is also used for material 
identifications and analysis. One major disadvantage of Raman scattering is the signal weakness. 
Raman signal intensity is orders of magnitude weaker than the elastic scattering. Only 1 in 107 
photons is scattered inelasticallj. Because the low probability of detecting the Raman signals, 
Raman scattering remained under-used for a quite long period of time. 
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1.1.2 Surface Enhanced Raman Scattering: 
In order to overcome the problem of low cross section of Raman scattering, scientists tried to 
increase the number ofprobed molecules using a roughened surface. In 1974, Fleischmann eta/ 
reported the observation of relatively high Raman scattering signals from monolayer of pyridine 
absorbed on a roughened silver electrode3• The high intensity of the Raman signals which was 
explained by the increase of the absorbed molecules due to the surface roughness remained a 
mystery for couple of years since it did not match the predicted calculation. In 1977, Vanduyne 
reported an enhancement factor as high as 106 for pyridine on a roughened silver electrode and 
claimed that the real reason behind the high Raman signal intensity is the surface enhancement 
effect4• Recently SERS has overcome most of the technical problems and become the main 
techniques used to detect and identify low concentration analytes for chemical sensing and 
biological applications. 
The main reason behind the Raman surface enhancement is the electromagnetic effect5• 
Briefly, the laser excites the roughened metal free electrons creating local charge oscillations. 
The later generate a high local electric field. Both incident and scattered light are affected by this 
enhanced field. As a result the Raman signal enhancement is proportional to the E4 . The second 
less important contributor to the Raman enhancement is the chemical effect6. This effect can be 
explained by the charge transfer that takes place between the absorbed molecule and the metal 
surface. 
It was predicted that any nanoscale features capable of sustaining surface plasmon excitation 
can be used as active SERS substrates. Recently, it has been reported that other than roughened 
metal surfaces, metal nanostructures such as Au nanoaprticles and nanorodes can form good 
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Raman active substrate. The collective oscillation of the free electrons on the nanostructure 
surface generates an enhanced local electric field. Similar to the roughened metal surfaces, the 
local electric field generated on the close vicinity of metal nanostructures can enhance the weak 
Raman scattering. Moreover, small aggregates of two or more nanostructures can further 
enhance the local electric field leading to much higher Raman enhancement. An enormous 
variety of metal nanostructures were explored as Raman active substrates mostly fabricated using 
metal nanoparticles deposited on a substrate, chemically roughened surfaces and 
lithographically fabricated nanostructures. In this thesis, Au nanoshells deposited on silica 
substrates are used as Raman active substrate. 
1.2 Gold Nanoshells 
1.2.1 Background and Physical Properties: 
Au nanoshells are plasmonic, spherical nanostructures consisting of silica (Si02) core 
wrapped with a thin layer of Au7• The interaction between the plasmons of the dielectric core and 
the metal shell grants Au nanoshell a set of particularly important optical properties. Arguably, 
the most significant property that distinguishes Au nanoshell from other metal nanostructures is 
being tunable from the visible to the near infrared (NIR) portion of the spectrum. This tunability 
can be easily controlled by adjusting the thickness of the Au shell with respect to the silica core 
during the fabrication process. Au nanoshells like other metal nanostructures support local 
plasmon oscillation and can form ideal SERS active substrates. The open topography of 
nanoshells allows detection and identification of large biomolecule such as DNA. Au nanoshells 
that resonate at the NIR are particularly important for biomedical applications ranging from 
diagnostic to therapy. Au nanoshells have been used for NIR bioimaging8' 9 and photothermal 
cancer therapy10- 12• The ease of conjugation of certain biomolecules such as single stranded 
5 
DNA (ssDNA), double stranded DNA (dsDNA) and peptides to the Au surface of nanoshells 
open doors for new applications in many fields such as drug targeting and delivery. The relative 
ease of cell uptake and biocompatibility of Au nanoshells allow in vivo applications and make 
nanoshells a potential candidate for future therapies which will allow diagnostic, delivery and 
controlled release of therapy all done on a single nanostructure. 
1.2.2 Nanoshells Fabrication: 
Au nanoshells are synthesized according to previously published procedures. 13• 14 The 
dimensions of the silica core (120 nm colloidal silica, Precision Colloids LLC, Cartersville GA) 
and the Au shell were chosen such that the peak plasmon resonance in aqueous suspension was 
800 nm, corresponding to the excitation wavelength used in all this work. Briefly, after cleaning 
commercial silica stobers by multiple washes with ethanol (200 proof), the silica cores are 
functionalized with 3-aminopropyltriethoxysilane (APTES, Sigma) overnight under vigorous 
stirring. The silane part of the APTES allowed covalent binding to silica nanospheres and the 
amine group of the APTES is available to attach to small Au nanoparticles. Separately, small 
gold nanoparticles ~2 nm in diameter are synthesized using 
tetrakis(hydroxymethyl)phosphonium chloride (THPC) as the reducing agent from the method 
reported by Duff, et a/. 15 After aging for at least 2 weeks, the small Au nanoparticles are 
incubated with the APTES functionalized silica nanospheres overnight. As a result, the small Au 
nanoparticles decorate the silica nanospheres serving as nucleation sites for metal growth. The 
ratio of silica particles to THPC-Au is estimated from the total surface area of the silica particle 
solution, the concentration and physical cross-section of the THPC-Au, and assuming 25 - 30 % 
coverage of THPC-Au on the silica surface. Typically, 1 M NaCl is used to increases the 
isoelectric point of the solution mixture by increasing the ionic strength, thereby decreasing 
6 
Columbic repulsion and increasing surface coverage of THPC-Au nanoparticles on the silica 
surface. The size of the THPC-Au nanoparticles (the smaller the better) and the surface coverage 
of THPC-Au on silica nanospheres (the higher the better) are the main contributors to the quality 
of synthesized nanoshells. The role of these parameters becomes more prominent when thinner 
Au shell is attempted. 
Once the seeds (silica cores decorated with small nanoparticles, Fig. 1.3 (i)) are ready, a 
plating solution is prepared separately. The plating solution is prepared by mixing 3 mL of 1% 
HAuCl4 solution (which was aged for 14 days) with 50 mg K2C03 in 200 mL of deionized H20. 
The plating solution must let set for at least 24-72 hours before being ready to be used. The last 
step consists of adjusting the ratio of the seed solution to the plating solution. This ratio 
determines the amount of Au deposited on the surface of the silica spheres thus the thickness of 
Au shell which determines the optical properties of synthesized nanoshells. It is worth to note 
that a reducing agent must be added to the seed/plating solution mixture. Formaldehyde has been 
used as the reducing agent to synthesize nanoshells for a long time, however lately Brinson et 
a!. 16 have demonstrated that carbon monoxide (CO) can alternatively used to reduce the Au salt 
and produce nanoshells of relatively higher quality. 
ii iii 
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Figure 1.3: Schematic diagram and corresponding TEM images showing nanoshell fabrication: 
(i) small Au particles attached to amine terminated silica nanospheres, (ii) start of the Au 
reduction, and (iii) complete Au nanoshell 
Figure 1.4: SEM sample of synthesized nanoshells using method described above 
1.2.3 Near-Field Properties o[Au Nanoshells: 
As mentioned earlier, the Raman enhancement that takes place at the surface of the Au 
nanoshell is due to enhanced local field which is a near field property. In order to understand the 
fundamental physics behind the local field enhancement, this section will give a brief 
background on the physical properties of Au nanoshell and particularly the near field properties. 
In this section Au nanoshell is modeled as shown in Figure 1.5.a. The inner radius (radius of the 
silica sphere) is r 1and the outer radius (radius of the nanoshell) is r2• s 1, s2 and s3 represent 
oi 
dielectric constants of silica (2.13), Au (cDrude-Lorentz(m)=l- 2 P. +L(m)) and the aqueous m +zrm 
medium (1.78), respectively. The interaction between light and Au nanoshell is treated on the 
quasi-static approximation. The quasi-static approximation simply means that the size of Au 
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nanoshell is small compared to the incident light wavelength which implies that the incident 
electric field does not vary spatially over the dimension of the Au nanoshell, the temporal 
variation is preserved. Practically, the quasi-static approximation is valid for Au nanoshells of 
diameters less than 80 nm. The quasi-static approximation simplifies tremendously the 
mathematical calculations and gives a pretty accurate description of the optical properties of Au 
nanoshell even for diameters larger than 80 nm. 
Given the incident electric field E(r, t) = E0e -iax, the electric field in the three regions of the 
nanoshell (region 1 = silica, region 2 = gold and region 3 = aqueous medium) is given by the 
.c. 11 . . 17 18 10 owmg equatiOn ' : 
Where ~,(r,O)= [ A,r+(:; )]cosO 
By adjusting the right boundary conditions, the electric fields at the three regions can be derived: 
Where 
Ea =E1 (3-2P)+2E 2 P 
E b = E 1 p + E 2 (3 - P) 
P=l-(;J 
9 
The important region for Raman enhancement is the region 3 (region outside the shell) where 
the entire field enhancement is taken place. At the region the induced field as similar to a dipole 
with an effective dipole moment given by: 
P £3 aE induced 
The polarizibility is given by: 
This interpretation shows that at the quasi -static approximation, the interaction of the Au 
nanoshell and the incident electric field generates an oscillating dipole. This dipole resonates 
when the polarizability a is maximized or the denominator reaches zero. 
b 
Figure 1.5: Au nanoshell near field properties. (a) schematic depicts the nanoshell parameters. 
(b) theoretical simulation shows nanoshell near field property. 
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The local near field at the nanoshell surface is calculated as E3 (in region 3). The nanoshell 
near field can be evaluated at appropriate distances from the surface by calculating the average 
of the field different points on the nanoshell surface. Figure 1.5.b illustrates the local field 
enhancement on the surface of the nanoshells. It also shows the decay of the local field that 
extends only few nanometers off the nanoshell surface. 19 
Designing the most appropriate SERS substrate that guaranties both high SERS enhancement 
factor based on high field enhancement as well as high signal reproducibility has been the main 
challenge on the SERS field. Theoretical calculations showed that interacting plasmon "motifs" 
such as dimers possess the largest field enhancement at the gap between adjacent particles and 
rapidly falls as a function of the interparticles distance.20 The debate between using higher order 
plasmon "motifs" ( dimers, trimers, etc) versus single particles has been lately resolved for the 
use of single particles for these reasons:21 
1. Even though theoretical calculations shows that the enhancement taking place at the 
dimers gap exceeds that on single nanoparticles by orders of magnitude, experimental 
data proves that the SERS enhancement produced by nanosphere dimers is only one order 
of magnitude greater than isolated nanoshells. Even more surprising, SERS enhancement 
on nanoshell dimers which theoretically should be one order of magnitude greater than 
nanosphere dimers, was comparable to isolated nanoshell22• The main reason behind 
these experimental observations is that the physical size of the gap between adjacent 
nanospheres (where the all enhancement takes place) is significantly smaller than the 
physical size of the enhanced area in a single particle. As a consequence increase in the 
11 
SERS enhancement in the case of the dimer gap in compensated by the decrease of 
probed molecule due to the limitation of the physical gap size. 
2. The physical size of the gap between adjacent nanoparticles prevents probing larger 
molecules such as DNA and proteins. The gap area will not be accessible for most large 
biomolecules which are of great interest. 
3. The fabrication of SERS substrates consists of nanoparticle dimers is extremely 
challenging and mostly involves the use lithography which is time and money 
consuming. On the other hand, substrate consisting of isolated particles is extremely easy 
and straightforward and requires only few steps of easy and known chemistry as will be 
described later. 
For all these reasons we preferred to use films of isolated nanoshells as SERS active substrates 
for all the SERS work on this thesis. The fabrication of the substrate will be discussed on detail 
later on. 
1.2.4 Thermal Properties o(Au Nanoshells: 
The combination of gold nanoparticles and biomolecules has enabled considerable advances in 
diagnostic and therapeutic nanomedicine. 23 In addition to biocompatibility and ease of 
fabrication and functionalization, the optical properties of certain noble metal nanoparticles are 
ideal for biomedical applications. The interaction of light with noble metal nanoparticles results 
in collective oscillations of the free electrons in the metal known as localized surface plasmons. 
On resonance, a metallic nanoparticle interacts strongly with incident light, possessing an 
extinction cross section nominally five times its physical cross section. Resonant illumination 
can result in strong light scattering (useful in biological sensing and imaging) and strong 
absorption, with relative magnitudes depending upon absolute nanoparticle size. As absorbers, 
12 
plasmon-resonant nanoparticles are unparalleled light-to-heat converters, dissipating energy via 
their lattice phonons. 24 
Due to their extraordinarily large absorption cross sections and their inability to re-emit 
light, the photothermal properties of metallic nanoparticles are arguably their dominant physical 
characteristic.25-27 The physical process underlying the photothermal response of metal-based 
nanoparticles has been studied quite extensively using time-resolved pulsed laser sources and 
techniques. 28-30 Whether a nanoparticle absorbs or scatters light is a function of its size: small 
nanoparticles are completely absorptive, while with increasing size the ratio of absorption to 
scattering cross section of a nanoparticle decreases in a complex manner. Ultimately, larger sized 
micron-scale particles are better scatterers than absorbers of light. Upon resonant illumination 
with an ultrashort laser pulse, absorptive metallic nanoparticles undergo a very rapid and 
dramatic increase in temperature (on the subpicosecond timescale). First, there is an initial 
transient regime where the electrons are at a much higher temperature than the atomic lattice of 
the nanoparticle. Following this initial rapid heating, the electron and lattice temperatures of the 
nanoparticle equilibrate on the timescale of a few picoseconds, consistent with the inverse of the 
highest phonon frequency in the material. Both theoretical and experimental studies indicate that 
nanoparticle surface temperatures that result can easily exceed the boiling point of water, 
sometimes by several hundreds of degrees,27 depending on the nanoparticle properties and 
illumination characteristics. In some cases this can result in a melting/reshaping of the 
nanoparticle, changing its optical absorption characteristics irreversibly.31 ' 32 If the light-
absorbing nanoparticle is immersed in a medium or fluid when illuminated, a nonequilibrium 
condition will exist between the hot nanoparticle and the cooler surrounding medium. At very 
low incident powers, this still can result in remarkably large temperature increases in the 
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surrounding medium due to the presence of the hot nanoparticle. 33 At the lower illumination 
intensities of interest in biomedical applications, the photothermal response of the nanoparticle 
can result in heating of the local medium surrounding the nanostructure, which can be used for 
photothermal tumor ablation by inducing hyperthermia, with resultant cell death.34 For the light-
assisted delivery of nucleotides, sufficient incident intensities must be used to initiate the process 
of DNA melting on the nanoparticle surface, but must be significantly below the intensities 
where photothermal cell death may result. 34-37 
The plasmon resonant frequencies of metallic nanoparticles depend strongly on particle 
geometry. The plasmon resonant frequencies of metallic nanoparticles can be tuned through the 
interaction, or hybridization, of plasmons supported by nanostructure geometry. 38• 39 This 
underlying principle, known as plasmon hybridization, has given rise to a large family of 
plasmonic nanoparticles whose resonances can be tuned to virtually any resonant frequency in 
the visible and infrared regions of the electromagnetic spectrum. For biomedical applications, a 
progression of gold nanostructures of various shapes and sizes has been developed with optical 
resonances in, or that can be tuned to, the near infrared (NIR) water window (690-900 nm).4042 
Blood and tissue are maximally transparent in this NIR spectral window, making it optimal for 
biomedical applications that utilize light.43 
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Figure 1.6: Au nanoshell characterization. Extinction spectra of Au nanoshells showing the 
maximum absorbance with respect to theIR window (dimensions"'"' [120,150] nm). Inset depicts 
the internal structure of a Au nanoshell. 
1.3 Gene Therapy: 
The fundamental definition of gene therapy is to insert or delete genes- the DNA 
sequences containing all information needed to express specific proteins- into cells, resulting in 
therapeutic benefits for specific diseases. The goal is to control and modify the expression of 
certain specific proteins associated with the cause or occurrence of a disease. When a protein is 
undesirably expressed by unhealthy cells, inhibiting its functionality or arresting its expression is 
a process known as downregulation: conversely, enabling protein expression is referred to as 
upregulation. Following the completion of the sequencing of the human genome, gene therapy is 
the next logical step in the development of advanced medical treatments for human disease. 
Recently, several approaches to gene delivery involving nucleic acids (DNA or RNA) 
have emerged as potential oligonucleotide-based therapeutic strategies for various diseases. 
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There are four major classes of oligonucleotide therapy:44 (i) Plasmid therapy, (ii) Antigene 
therapy, (iii) Antisense and short interfering RNA (siRNA) therapy, and (iv) Aptamer therapy 
(Fig. 1 ). Plasmid therapy targets DNA and introduces new genes that express proteins missing in 
cells. Plasmids are long, double-stranded DNA containing the foreign genetic code, delivered 
inside cells, to diffuse into the nucleus and become incorporated into the cell's genetic material. 45 
Once integrated with the cell's DNA, plasmids become part of the genetic material, allowing 
continuous expression of a specific missing protein. Antigene therapy directly targets and binds 
to specific segments of DNA, preventing transcription to the mRNA and thus protein expression. 
Antisense and siRNA therapies target messenger RNA (mRNA), the intermediary between DNA 
and functional protein, and can selectively inhibit the expression of a specific protein. Antisense 
is based on hybridizing a short ssDNA sequence (15 to 30 bases) to its complementary region on 
the mRNA; once bound, it blocks further translation of the specific mRNA, arresting protein 
synthesis.46 siRNA is a double stranded RNA sequence, nominally 20 bases long, containing the 
complement of the target mRNA. siRNA therapy involves a more complicated mechanism, 
where a combination of molecular complexes destroy the target mRNA and result in gene 
silencing.47 Aptamers are short single or double stranded DNA that have been combinatorially 
selected to recognize and bind to specific target proteins post-translationally, inhibiting their 
functionality for therapeutic benefit.48 Here we focus on antisense oligonucleotide delivery. 
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Figure 1.7: Schematic of the four major types of DNA-based therapies. Plasmid DNA enters the 
nucleus and biosynthesize new healthy protein. Antigene oligonucleotides enter the nucleus, 
form a triplex with the genomic DNA, and block transcription. Antisense oligonucleotides bind 
to mRNA, located in the cytoplasm, and block translation. Aptamers act as a conventional type 
of drug by targeting the malfunctioning protein directly. 
Antisense therapy was first suggested by Stephenson and Zamecnik 30 years ago. 49 The 
principle of antisense therapy is very simple: design a short single-stranded oligonucleotide to 
hybridize to a particular messenger RNA (mRNA) target, which then inhibits the translation of 
that specific mRNA sequence into its corresponding protein. Antisense therapy has been 
suggested as a therapeutic strategy for cancer, viral infections and inflammatory diseases. 5° 
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1.3.1 The Challenges o(Gene Therapy Vector Design: 
However, there are several major inherent challenges to antisense delivery that have impeded 
its translation into clinical practice. 51 Oligonucleotides by themselves cannot be injected directly 
into the bloodstream for systemic delivery, due to their rapid degradation (< 20 minutes) by 
serum nucleases. A carrier that protects the oligonucleotides from enzymatic degradation is 
therefore essential to any practical delivery strategy. The DNA carrier must also be small enough 
and possess favorable chemical properties to extravasate (be removed from the bloodstream), be 
taken up by cells, deliver the oligonucleotide cargo into the cells of interest, and access the cell's 
genetic material so that it is available to perform its therapeutic mission. Intracellular uptake of 
foreign materials or structures, a process known as endocytosis, typically results in sequestration 
of the foreign object within an endosomal compartment inside the cell. Here again, the 
oligonucleotide may be subject to enzymatic degradation within the endosome. For the 
oligonucleotide to have its intended therapeutic effect it must be released, or diffused from, the 
endosomal compartment into the cytosol and within an effective distance of the cell nucleus or 
ribosome, depending on its specific gene target. Originally, viruses were proposed as delivery 
vectors for gene therapy, because their own replication requires the injection of their genetic 
material into cellular hosts. Despite their inherent effectiveness in delivering oligonucleotides in 
vivo, viral vectors have induced unexpected and highly deleterious immune system responses in 
clinical subjects resulting in death, which is likely to prevent their ultimate approval for clinical 
use. 52 
To realize the promise of gene therapy as a new tool in advanced clinical medicine, safe 
and effective nonviral delivery vectors are critically needed. 53' 54 An ideal non viral gene therapy 
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vector would have several important properties. It would [1] induce no immunogenic response, 55-
57 [2] maintain high stability against nucleases in the circulatory system, 58• 59 
[3] target, and endocytosis into, specific cells of interest,60 and [4] provide a means for the 
efficient release of oligonucleotide cargo from the endosomal compartment. These requirements 
have led to a strong and growing interest in gold nanoparticles of various shapes and sizes as 
nonviral vectors for gene therapy. The biocompatibility of gold nanoparticles and nanostructures 
is well established. Oligonucleotides can be bound to the surface of a gold nanoparticle in 
relatively dense monolayers, greatly increasing their stability against degradation by nucleases. 
The facile binding of various types of biomolecules to the surfaces of gold nanoparticles enables 
multiple functions to be imparted on the same nanoparticle "platform": for example, combining 
oligonucleotide loading with antibody conjugation for targeting specific cells or tissues is 
realizable with this approach. Finally, remote-controlled release of DNA from a nanoparticle 
complex is made possible by the resonant optical properties of gold nanoparticles and 
nanostructures.61 -64 Resonant light absorption provides both spatial and temporal control for 
oligonucleotide release, which could be highly useful in research as well as in treatment 
scenarios. In addition, the energy input due to resonant light absorption and the accompanying 
local photothermal heating response may also assist diffusion of the oligonucleotides out of the 
endosomal compartment. In particular, nanoparticle-based complexes that respond to near 
infrared light, at wavelengths not significantly absorbed by cellular material, and release DNA 
upon resonant illumination would provide an ideal platform for light-controlled gene therapy. 
1.3.2 Gold Nanoparticle-based Vectors (or Gene Therapy: 
DNA can be bound to Au nanostructures by simple thiol chemistry or electrostatic 
attachment. DNA attached to Au nanostructures has an increased half-life from minutes to 
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hours58 against attack by large nucleases due to the increased steric hindrance caused by 
attachment to the Au surface. 58 Additionally, polyvalent cations near the Au nanoparticle 
surface electrostatically repel dications located within the nucleases, also increasing 
oligonucleotide stability. 65 
Increasing the cellular uptake efficiency of therapeutic DNA is necessary for effective 
therapy. The attachment of either therapeutic oligonucleotides (DNA, siRNA) or existing 
transfection agents (cationic liposomes, cationic polymers, dendrimers) to gold nanoparticles has 
been shown to universally increase cellular uptake and transfection efficiency. DNA/siRNA 
molecules condense when attached to the gold surface. Attaching other nonviral gene delivery 
vectors, such as lysine dendrimers, to gold nanoparticles has been shown to increase gene 
transfection 28-fold relative to the dendrimer alone.54 Following cellular uptake, the 
oligonucloetides must be able to escape from the endosome, diffuse through the cell, and interact 
with the cell's genetic material. Currently, subsequent to cellular uptake, the DNA-bearing 
carriers are believed to be sequestered in the endosome. It is currently hypothesized that the use 
of light activated plasmonic nanostructures can effectively disrupt the endosome and release the 
DNA into the interior of the cell. Wu et al. have observed that light-induced endosomal 
disruption occurs with pulsed laser irradiation, and suggested that transient cavitation of vapor 
microbubbles that form between the temperature gradient on the surface of the plasmonic gold 
nanoparticle and the surrounding medium are responsible for this disruption.66 
A summary of different Au nanostructure-based gene therapies reported to date is shown 
in Table 1. Cellular delivery of DNA/RNA conjugated to Au nanoparticles can be effectively 
accomplished either with or without light activation. Without light activation, when the Au 
nanostructures are merely serving as carriers for transferring genetic material into cells, they do 
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elicit a therapeutic response, either downregulation ,(15, 67 or enhanced gene expression.68 In 
general, however, the limited yield of non-light-activated therapy limits this therapeutic strategy. 
Light-responsive delivery vectors appear to overcome these challenges quite effectively and may 
be therapeutically more beneficial for controllable gene release than the non-light-activated 
approach. 
Type of Au Wavelength DNA/RNA Binding Type of Gene Therapeutic Ref 
Nanostructure of Response Chemistry Therapy Target 
Nanorods 900nm Nanorods capped with Light Plasmid DNA 
phosphatidylcholine activated release 69 
interact with DNA 
electrostatically 
Nanorods 780-1100 Thiolated DNA Light DNA release, "/U 
nm covalently attach to Au activated GFP gene 71 
surface expression, 64 
BlockmRNA 
translation of 
ERBB2 
Hollow 800nm Thiolated polyethylene Light RNA 72 
Nanoshells glycol-RNA chemically activated interference 
bound to Au surface 
Nanospheres 520nm Nanoparticles Light T7RNA (>j 
positively charged with activated polymerase 
dimethylethyl-
ammonium interact 
electrostatically with 
DNA. 
Nanospheres 520nm Ethylene glycol- Non-light Firefly (>7 
alkylthiol modified activated luciferase 
RNA attach chemically downregulation 
to Au surface 
Nanospheres 520-560 nm Plasmid DNA Non-light Enhanced green 73 
electrostatically activated fluorescent 
attached to Au protein 
encapsulated in expression 
cationic liposomes 
Nanospheres 520nm Positively charged Non-light Murine IL-2 74 
aminated nanoparticles activated mRNA 
electrostatically attach expression 
to plasmid DNA 
Nanospheres 520nm Nanoparticles bearing Non-light J3-galactosidase o!S 
primary ammonium activated reporter gene 
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----------------
groups bind with expression 
anionic DNA via ion-
pairing 
Table 1.1 A summary of different Au nanostructures utilized for light activated and non-light 
activated gene therapy, their wavelength of response, DNA attachment chemistry, and 
therapeutic target. 
As can be seen in Table 1, the combination of Au nanoparticles and light-activated DNA 
release has been recently identified by numerous groups as a potentially useful strategy for 
increased effectiveness in gene therapy. Several variations of this general approach have been 
demonstrated. DNA has been attached to functionalized Au nanoparticles via photoactive ester 
linkages, where near-UV irradiation has been used to cleave the ester moieties, releasing the 
DNA. 63 The potential practical biomedical applicability of this specific approach is limited, since 
for in vivo applications, NIR irradiation (650-900 nm) is highly preferable to near-UV light due 
to its far deeper penetration in tissue/5 as well as its negligible mutagenicity relative to near-UV 
light. Therefore, plasmonic nanoparticles with resonances in the NIR region of the spectrum, 
such as nanoshells and nanorods, are preferentially being pursued. Nanorods either 
electrostatically attached to DNA69 or covalently bound to thiolated DNA through the Au-S 
bond70• 71 were shown to release DNA when excited with a NIR pulsed laser at the plasmon 
resonance. However, pulsed laser irradiation may reshape nanorods, which can modify their 
aspect ratio and their optical properties, including their resonant frequency. 71 Modifications in 
the nanorod geometry will reduce or eliminate the NIR absorption of these nanoparticles, and 
could effectively tum offNIR light-controlled release. Moreover, in biomedical applications, the 
reshaping of nanoparticles may also modify their pharmacokinetics and biodistribution, which 
may affect their safety and delay or eliminate their ultimate approval for human use. The melting 
and reshaping of nanorods can be circumvented by using a continuous wave laser. 64 Lee et al. 
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conjugated thiol-modified dsDNA to nanorods, released the oligonucleotides upon NIR 
illumination, and successfully blocked the translation of ERBB2 mRNA in BT474 breast 
carcinoma cells. However, a very low percentage of cells showed protein downregulation: 
further studies are warranted to quantify this response. Still, the overall strategy of near-IR 
triggered oligonucleotide release from Au nanoparticle-based vectors is highly promising. 
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Chapter 2: Surface Enhanced Raman Spectroscopy of DNA 
2.1 Introduction: 
Detection of DNA, arguably the most important biological molecule, is the basis of 
numerous technologies ranging from diagnostic screening in clinical medicine to forensic testing 
in law enforcement. 76' 77 The vast majority of current DNA detection methods involve the use of 
fluorescent reporters as part of the signal transduction, requiring costly chemicals and complex 
chemistry. 78 Surface-enhanced Raman spectroscopy (SERS), with its demonstrated ability to 
detect single molecules such as the DNA base adenine, has generated tremendous interest as a 
potential strategy for label-free biomolecule detection.79' 80 While numerous SERS studies of 
DNA have been performed to date, sensitive and reliable acquisition of SERS spectra from DNA 
samples remains a significant challenge. For example, in one study it was reported that while all 
dsDNA samples yielded SERS spectra with good signal to noise ratio, none of the ssDNA 
oligomers studied yielded detectable SERS signals.81 Another study reported that the quality of 
the SERS spectrum of single stranded Calf Thymus DNA was much better than that of the 
double stranded DNA. 82 More recently, SERS detection of both single and double stranded 
DNA was reported, where the observed SERS features appeared to be sequence and/or 
composition dependent, 83 
It has now been shown in several detailed investigations that Au nanoshells, spherical 
nanoparticles whose plasmon resonance frequencies are controlled by the relative inner and outer 
radius of their metallic shell layer, can be used as highly reproducible SERS substrates. 19• 22• 84• 
85 Although nanoparticle dimers separated by nanometer scale gaps are known to produce larger 
SERS enhancements, known as "hot spots", fabrication of dimer-based substrates with highly 
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regular, reproducible hot spots is quite challenging. 86• 87 A major problem with adjacent 
nanoparticle pairs as SERS substrates is the very sensitive dependence of the SERS enhancement 
on interparticle spacing. Fortunately, the amplitude of the integrated SERS enhancement of 
single nanoshells can be comparable to that of a solid nanoparticle dimer with a nanometer scale 
gap. 22 With the SERS enhancement designed and built into each individual nanoshell particle, 
the challenging requirement of fabricating nanometer-scale spacing between adjacent 
nanoparticles is virtually eliminated. 19• 88•89 For many applications in chemical spectroscopy and 
sensing, the easily accessible, open surface topology of nanoshells presents a far more preferable 
substrate for surface-enhanced spectroscopies than the closed topology of nanoparticle dimers or 
aggregates. This open topology is critically important for biomolecular spectroscopy and 
sensing, since the spatial extent of many biomolecules of interest, DNA being a prime example, 
may exceed the nanoscale dimensions of dimer "hot spots". In addition to the large field 
enhancements on nanoshell surfaces, the plasmon resonant properties are remarkably insensitive 
to defects on the particle surface or to nanoscale roughness,90 making them ideal substrates for 
assessing SERS spectral reproducibility. The development and use of highly reproducible 
substrates is critical in the advancement of SERS as a mainstream spectroscopic technique. This 
is particularly important in studies of large, complex molecules such as DNA or proteins, since 
the SERS signal in these molecules already depends significantly on molecular conformation, 
orientation, and binding specificity to the substrate surface. 
In this chapter we report a study of the surface-enhanced Raman spectroscopy of 
thiolated ssDNA and dsDNA oligomers bound to Au nanoshell-based SERS substrates. In this 
study the SERS features of DNA are easily recognized. Previous studies have shown that 
spectral quality and reproducibility can be severely limited by large variations in molecular 
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conformation and/or packing density of the DNA adsorbate molecules on the substrate. Here we 
show that a gentle thermal cycling pretreatment of the ssDNA and dsDNA prior to adsorption 
onto the nanoshell substrate results in a relaxation of the DNA molecules into what we believe to 
be an extended, "linear" conformation. This procotol results in a dramatic increase in the 
reproducibility of the SERS spectrum. The spectra obtained using this preparation method show 
an overwhelming dominance of adenine Stokes modes in the SERS spectra, with much weaker 
secondary features occasionally observable from other bases, most predominantly guanine. The 
reproducibility of the SERS spectra decreases slowly over time (several days) as the molecular 
conformations re-randomize, where an increase in spectral variation consistent with an increased 
distribution of molecular conformations is observed in the SERS spectra. 
In the context of this study we introduce a new quantitative spectral analysis approach 
useful for SERS. We define a Spectral Correlation Function (SCF), r, that provides a metric with 
which to assess the reproducibility of SERS spectra or, alternatively, to quantify complex 
changes in the SERS spectrum that may be due to chemical modification of the adsorbate 
molecules (see Analysis section). We apply this analysis to quantitatively assess the 
improvements in DNA spectral reproducibility due to our thermal pretreatment protocol. SCF 
analysis also allows us to monitor complex changes in the SERS spectrum of adsorbate 
molecules due to chemical modification of the DNA. As an example, we apply SCF analysis to 
monitor the changes in the SERS spectrum of DNA upon interaction with cisplatin, a 
chemotherapeutic agent in widespread use for cancer treatment. This class of anticancer 
compounds is known to induce cell death by binding directly to DNA in cells, arresting cell 
replication and activating signal transduction pathways that ultimately lead to apoptosis. Our 
Spectral Correlation Function (SCF) analysis is of direct practical interest in the development 
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and quantification of high-performance, high-reproducibility SERS substrates. This approach 
also successfully discriminates changes in the SERS spectrum of DNA upon exposure to 
cisplatin in comparison with its trans analog, transplatin, known to have a much lower affinity 
for DNA and therefore useful in this study as a control molecule. 
2.2 Experimental: 
Nanoshell-based SERS substrates consisting of dispersed nanoshells bound to glass 
substrates were prepared.91 ' 92 Briefly, a fused quartz microscope slide (Piranha cleaned) was 
incubated overnight in an (1%) ethanolic solution of poly( 4-vinylpyridine) (MW = 160,000 from 
Sigma-Aldrich) and dried with nitrogen gas; subsequently 100 Jll of aqueous nanoshell 
suspension was deposited onto the substrate. The substrate was then allowed to sit at room 
temperature for 3-4 h before rinsing with Milli-Q water (Millipore, Billerica, MA) to remove 
excess nanoshells, followed by drying with a gentle flow of nitrogen. 
Oligonucleotide Sequence (5'-3') 
ST2oN1 SH-C6-TTTTTTTTTTTTTTTTTTTTGCGGCAATCAGGTTGACCG 
(70 bases) TACATCATAGCAGGCTAGGTTGGTCGCAGTC 
SA2oN2 SH-C6-AAAAAAAAAAAAAAAAAAAACGCCGTTAGTCCA 
(70 bases) ACTGGCATGTAGTATCGTCCGATGCAACCAGCGTCAG 
ST2oN3 SH-C6-TTTTTTTTTTTTTTTTTTTTGCGGCTTTCTGGTTGTCCGT 
(70 bases) TCTTCTTTGCTGGCTTGGTTGGTCGCTGTC 
SN4 SH-C6-GACTGCGACCAACCTAGCCTGCTATGATGTACGGTCAA 
(50 bases) CCTGATTGCCGC 
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SN5 
SH-C6-GACTGCGACCAACCTAGCCTGCTATGATGT 
(30 bases) 
SN6 
SH-C6-TCTTGCTGTGTCTGTTCTTT 
(20 bases) 
Table 2.1: Oligonucleotide sequences used in the described experiments. 
To study the possible sequence dependence of the SERS of DNA, several DNA 
oligomers of different lengths and compositions (Table I, purchased from Integrated DNA 
Technology Inc.) were studied. Prior to use, all thiolated DNA oligomers were reduced with 1,4-
Dithio-DL-threitol (DTT, Fluka) and purified with NAP5 purification columns (GE Healthcare). 
Unthiolated DNA sequences were used as received, having been HPLC-purified by the vendor. 
DNA uncoiling was achieved ex-situ (not on the substrate) by heating the DNA solutions in TE 
buffer (1x Tris EDTA buffer pH = 7.5 from IDT) to 95°C for 10-15 min. followed by rapid 
cooling in an ice bath. DNA prehybridization was carried out ex-situ by mixing two 
complementary DNA sequences at a 1: 1 molar ratio in DNA hybridization buffer (TE/50mM 
NaCl, pH = 7.5), heating the solution to 95°C, then allowing it to cool slowly to room 
temperature in a large water bath. To bind DNA to the nanoshell SERS substrates, 50 J.LL of the 
(typically 40 J.LM) target DNA (ssDNA/dsDNA) were deposited onto a freshly made nanoshell 
SERS substrate. After overnight incubation, the excess ssDNA or dsDNA solution was removed 
by rinsing with TE or TE/50 mM NaCl buffer, respectively. 
For the cisplatin/transplatin experiments, 30 bp prehybridized dsDNA (SN5) was 
immobilized on nanoshell-SERS substrate and then incubated with 7.5 nM mercaptohexano1 
(MH, Sigma-Aldrich) for 7 hours to remove nonspecifically bound DNA and prevent the direct 
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interaction of the cis- and transplatin with the Au surface. Subsequently, 1 mM (aq) cisplatin or 
transplatin (Sigma-Aldrich) was added. Samples were rinsed with TE/50 mM NaCl buffer prior 
to SERS acquisition. 
SERS spectra were recorded while substrates were immersed in the appropriate buffer 
(TE for ssDNA and TE/50 mM NaCl for dsDNA) using a Renishaw inVia Raman microscope 
(Renishaw, U.K.) with 785 nm excitation wavelength. Backscattered light was collected using a 
63x water immersion lens (Leitz, Germany), corresponding to a rectangular sampling area of 3 
J..Un x 30 J..Un. Unless stated otherwise, all the SERS spectra in this work were obtained with an 
integration time of 20 seconds and a laser power of 0.57 m W before the objective. 
Normal Raman spectra of DNA oligomers were acquired with the drop coating 
deposition Raman (DCDR) method.93 In this protocol, 10 J..LL of the 40 J..LM purified DNA 
sample was deposited onto spectRIM substrates (Sigma-Aldrich). Because of the so-called 
"coffee ring" effect, the DNA forms a ring on the substrate after drying in a vacuum assisted 
desiccator. The normal Raman spectra were acquired using a 50x dry objective. An integration 
time of 900 s and a laser power of 570 m W before objective were used for all the normal Raman 
spectral acquisitions. 
2.3 Analysis: 
To quantitatively analyze the reproducibility of the SERS spectra, a dataset of N spectra 
(in this work, typically N = 8) acquired at randomly selected regions on the same substrate was 
obtained. Correlation coefficients between all nonidentical spectral pairs (i ¢ j) in the same 
dataset were determined from the data using: 
w - -
:Lci;(k)- I;)(/j(k)- Ij) 
P, . = ..::.k-;;;.:.1 _______ _ 
1,] (1) 
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where i, j is the index of the spectra in the data matrix, k is the wavenumber index of the 
individual spectra, I is the spectral intensity, W is the spectral range, and Of is the standard 
deviation of the ith spectrum. Once the correlation coefficients PiJ are calculated, a Spectral 
Correlation Function r, the average of the off-diagonal correlation coefficients, can then be 
determined: 
N N 
2"" ""P, . LJ LJ 1,) 
i=l j"=i+l r=----=---
N(N-1) (2). 
r values can be used for quantitative assessment of spectral reproducibility, with values that vary 
from 1 in the case of identical spectra to 0 in the case of completely uncorrelated spectra. 
Changes in SERS spectra can be quantified using the correlation coefficients ~~·P with all 
possible spectral pairs originating from spectral measurements a and J3 respectively. 
w -
:L (Iia ( k) - In(!) ( k)- I)) 
pa,p = ..!!.k:::!-I _____ -=------
1'1 a'!a~ 
I J 
(3) 
ra,p = i=l j=l 
MN (4) 
In this case, a and J3 may represent spectra from two different substrates, or spectra 
obtained from the same sample at two different times. Here i, j index the spectra obtained with 
substrate a and J3 respectively, and M and N refer to the total number of spectra analyzed. Prior 
to correlation analysis, all spectra were processed with a Savitzky-Golay second derivative 
method (window size of 15 data points with 2nd order polynomial), which can effectively reduce 
or eliminate possible false correlations resulting from a constant offset or broadband 
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background. 94 The larger the ra,f3 value, the higher the value of the spectral correlation function 
between the sets of spectra. 
Spectral variations induced by cisplatin/transplatin binding to DNA were analyzed using 
Equations (3) and (4). In this case, a, ~ refer to the DNA-nanoshell sample before and after 
cisplatin/transplatin treatment. The average correlation ru·l3, is a quantitative assessment of 
spectral variations induced by the sample treatment. Clearly, the smaller the ru·l3 value, the more 
significant the spectral changes that have occurred. The spectral range evaluated in this analysis 
was 350 cm-1 to 1700 cm-1• 
2.4 Results and Discussion: 
Figure 1.1 shows multiple SERS spectra of untreated and thermally cycled ssDNA 
(SA20N2, Table 1.1 ). Extremely large variations in SERS spectra are typically obtained for 
untreated DNA samples (Figure l.l.a). Following thermal pretreatment (heating of the DNA in 
solution followed by rapid cooling, then adsorption onto the substrate), the SERS spectra appear 
dramatically different and highly reproducible (Figure l.l.b ). To evaluate this change in spectral 
reproducibility, r was calculated for the spectra with and without thermal pretreatment (Figure 
1.1, inset). Also shown are the r values obtained from a series of SERS spectra of prehybridized 
dsDNA for the same base sequence (with its complement) and a mixture of the same two 
complement sequences without thermal pretreatment. Using this analytic approach it is clearly 
seen that the thermally treated ssDNA and the thermally treated, pre-hybridized dsDNA have far 
higher r values (r ~ 0.9) than the untreated samples (r ~ 0.1-0.2). Very similar SERS spectra 
and spectral reproducibility were observed for all other adenine-containing DNA sequences 
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listed in Table 1.1 , suggesting that the observed increase in spectral reproducibility is remarkably 
sequence independent, at least for the variety of DNA oligomers studied here. 
In the preparation of dsDNA for these studies, the SERS spectra and their spectral 
reproducibility for the mixture of untreated DNA and its complement in solution were observed 
to be extremely similar to those observed for untreated ssDNA. From this observation we 
conclude that without thermal pretreatment it is unlikely that extensive hybridization occurs for 
these experimental conditions. Substrate-to-substrate spectral reproducibility was also analyzed 
for thermally pretreated ssDNA and dsDNA samples. Although the overall SERS intensity can 
vary from substrate to substrate due to variations in nanoparticle density, 84 the SERS spectral 
features are highly reproducible, with r > 0.98 in all cases. 
400 800 1200 1600 
Raman Shift (cm-1) 
Figure 2.1: Typical SERS spectra of (a) untreated ssDNA and (b) ssDNA following thermal 
pretreatment. Spectra are offset for clarity. Inset: r values for series of 8 SERS spectra for (i) 
untreated ssDNA from (a), (ii) untreated ssDNA plus complement, (iii) thermally pretreated 
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ssDNA from (b) and (iv) thermally pretreated dsDNA. Error bars represent one standard 
deviation. 
The dramatic differences in SERS spectra and spectral reproducibility between the 
untreated and the thermally-pretreated ssDNA samples can be attributed to thermally induced 
uncoiling of ssDNA prior to attachment to the substrate. We believe this treatment results in 
extended ssDNA chains with a significantly greater uniformity of molecular conformation than 
untreated, randomly coiled ssDNA chains. Adsorption of the thermally pretreated, relaxed 
ssDNA onto the nanoshell substrate surface is quite likely to also result in a more ordered and 
densely packed monolayer on the nanoparticle surfaces relative to ssDNA adsorbed in randomly 
coiled conformations. Increased adsorbate order and packing density on the nanoshell substrate 
surfaces would also enhance the uniformity and reproducibility of the observed SERS signals. 
Since the persistence length of dsDNA can be as long as 50 nm,95 corresponding to -147 base 
pairs, all the hybridized dsDNA investigated in these studies are likely to adopt a rigid rodlike 
structure. Thus, just as with the thermally pretreated ssDNA, the similarly prepared dsDNA is 
also likely to bind to the nanoshell substrates with increased ordering and a higher packing 
density. 
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400 800 1200 1600 
Raman Shift ( cm-1) 
Figure 2.2: SERS spectra of(a) adenine, (b) thermally pretreated single stranded and (c) 
double stranded SN5. Each spectrum is an average of 8 spectra collected from different spots of 
the same sample. Spectra are scaled and offset for clarity. 
2.4.1 Adenine-Dominated SERS Spectra: 
In Figure 2.2, a direct comparison of the SERS spectra of adenine with the SERS spectra 
of the thermally pretreated thiolated ssDNA and dsDNA (thiolated ssDNA hybridized with its 
unthiolated complement) SN5, a random sequence 30-base oligonucleotide listed in Table 1.1 , is 
shown. It is clearly observable that both the SERS spectra of ssDNA and dsDNA for SN5 are 
overwhelmingly dominated by the SERS features of their adenine constituents. This dominance 
of the adenine features observed in this case was observed in all the SERS spectra of thermally 
pretreated ssDNA and thermally pretreated, prehybridized dsDNA, regardless of the position or 
percentage of adenine in the sequence. 
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Figure 2.3: (a) Normal Raman of(i) ST20Nl and (ii) SA20N2 (b) SERS spectra of(i) ST20N1 
and (ii) SA20N2. Spectra are offset for clarity. Major peaks in the normal Raman spectrum of 
S T A20N2 are assigned. 
WaveNumber 
678 
729 
785 
1098 
1336 
1485 
1576 
Assignments 
G 
A 
T,C 
bk (P0-2 st) 
A 
A,T,C 
A (ring st, N6H2 df) 
A, adenine; T, thymine; G, guanine; 
C, cytosine; bk, backbone; st, stretch; df, deformation. 
Table 2.2: Assignments of normal Raman bands of SA20N2. 
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This can be seen quite dramatically in the SERS spectra of thermally pretreated ST 20Nl 
and SA2oN2 oligomers, each a 70-base sequence (Figure 2.3). The adenine content in the two 
DNA sequences, 15.5% and 44.3%, respectively, vary significantly. In addition, the adenine 
position in each sequence is quite different: for ST20Nl, the first adenine is 26 bases away from 
the thiol group (and therefore the Au surface), where for SA20N2, 20 adenine bases are directly 
adjacent to the thiol group. Interestingly, the SERS spectra ofthe two DNA sequences were very 
similar (Figure 2.3.b), both dominated by adenine modes. Since poly(T) and poly(A) sequences 
are known to have significantly different packing densities on Au surfaces, a direct comparison 
of SERS intensities does not yield quantifiable enhancement information, and therefore the 
SERS spectra in Figure 2.3.b are normalized.96' 97 In contrast, their normal Raman spectra 
(Figure 2.3.a) reveal significant composition dependence. Mode assignments are provided in 
Table 2.2 for these spectra. 
These data suggest that, under our experimental conditions and for the selection of 
molecules we have studied, that the dominance of the adenine modes in the observed SERS 
spectra is not due to abundance of adenine base nor to the relative proximity of the adenine bases 
to the gold surface. The SERS signal itself from the adenine bases appears to be more greatly 
enhanced than that of the other DNA bases. The only SERS spectral signature from the other 
DNA bases that is observable is the weak 667 cm-1 peak, attributed to the ring breathing mode of 
guanine. 81 ' 98• 99 This much weaker feature appears in the SERS spectra of both the ssDNA and 
dsDNA, but is absent from the SERS spectrum of adenine. Stokes modes from thymine and 
cytosine, and the backbone constituents of ribose and phosphate, are indiscernible. 
One may possibly conclude that based on our experimental observations, the thermally 
pretreated DNA oligomers may be lying down and in direct contact with the Au surface of the 
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nanoparticle as an explanation of the consistent dominance of the adenine SERS modes. 
However, we have observed that the SERS of nonthiolated DNA, which is most likely to be 
lying flat on the gold surface, is quite different in terms of relative intensity of adenine (736 cm-
1) and guanine (667 cm-1) peaks than its thiolated DNA counterpart (unpublished). Moreover, 
experimental100 and theoretical101 studies have suggested a strong correlation between packing 
density and DNA conformation. The packing density of DNA chains on the gold nanoshell 
surface is quite likely to affect their conformation (and vice versa). At higher packing densities 
both single stranded and double stranded thiolated DNA would preferentially extend from the Au 
surface. On the other hand, loosely packed DNA chains may prefer to lie flat and in contact with 
the Au surface, stabilized by DNNAu interactions. 102 DNA-Au simulation studies taking into 
consideration DNA base pair stacking, electrostatic interactions, electrolyte effects, in addition to 
DNA-Au interactions are critically needed to better understand the precise conformation of 
thiolated and unthiolated DNA on Au surfaces. 
To further understand the relative signal contributions of the different DNA bases, SERS 
spectra of thermally pretreated single stranded ST 20N3, a thiolated 70-base oligomer that 
contains no adenine, and a prehybridized double stranded ST 20N3 with its complement, were 
obtained (Figure 2.4). As expected, in the absence of adenine, the guanine features are seen to 
dominate the DNA SERS spectra. It is worthwhile to note that there are no detectable features 
from either cytosine or thymine in the SERS of ST 20N3, supporting a conclusion that the SERS 
cross section of adenine >> guanine >> cytosine and thymine. 
Several reasons could explain the dominance of adenine in the SERS spectra. One 
possibility is that DNA degrades during thermal pretreatment of our DNA oligomers, resulting in 
adenine bases or base containing fragments binding directly to the Au surface thus yielding a 
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preferentially large SERS signal. This possibility was carefully examined by gel electrophoresis 
analysis of our DNA oligomers following thermal cycling, which confirmed that the thermal 
pretreatment is entirely nondestructive and does not compromise DNA integrity. Furthermore, 
when the pretreat~d, uncoiled ssDNA samples, now bound to the nanoshell substrates, were 
reheated then allowed to cool slowly, the reproducibility of the SERS spectra of the reheated 
samples was measurably decreased. This is most likely due to partial, random DNA recoiling 
occurring during the slow cooling step. If thermal cycling caused partial DNA dissociation, then 
additional heating would likely result in further DNA dissociation and an increase in the SERS 
signal from the additional available adenine, which is not what is observed. These observations 
lead us to conclude that the most likely reason that adenine dominates the SERS spectra of DNA 
is that adenine possess a significantly higher SERS cross section than the other DNA bases. 
The dominance of adenine due to its higher SERS cross section is consistent with other 
previously reported SERS studies of DNA. For example, in an equimolar mixture of poly(A), 
poly(G), poly(C) and poly(T), it was found that the SERS intensities of the ring breathing modes 
showed an order of A> C >> G ~T.83 Tip-enhanced Raman spectroscopy (TERS) of single 
DNA bases in self-assembled monolayers on Au(lll) showed the intensity of the adenine 
breathing mode to be far higher than that of guanine, which in turn was higher than cytosine and 
thymine. 103 This observation is consistent with our experiments. It is also important to note that 
adenine is the only DNA base that exhibits single molecule detectability while the lowest 
reported detection limits for the other DNA bases are in the sub !-LM range80. 
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Figure 2.4: (a) SERS ofuncoiled ST20N3 (adenine-free 70 base ssDNA). (b) pre-hybridized 
dsDNA (ST 2oN3 with its complement). 
In previous SERS studies of DNA on nanoshell substrates it was determined that LsERs, 
the effective 1/e distance above the nanoshell surface where SERS enhancement could be 
detected for nanoshells of this size, is nominally 9 nm. 19 The observations reported here are 
consistent with this LsERS· Assuming a tilt conformation for thiolated DNA chains on the Au 
surface supported by simulation studies, 104 approximately the first 30 to 40 bases closest to the 
Au surface would lie within the LsERS for this substrate. In the case of ST 20Nl, the first adenine 
is 26 bases away from the Au surface, still within the LsERs for this nanoshell substrate. In this 
case, the high SERS cross section of adenine compensates for the weaker SERS enhancement 
experienced by this moiety at its distance from the nanoshell surface. 
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2.4.2 Detection o[DNA Interaction with Cisplatin and Transplatin: 
Having achieved highly reproducible SERS spectra of DNA by this method, we apply 
this approach to detect and discriminate conformational changes induced by the interaction of 
DNA with the two platinum ligands cisplatin and transplatin. 
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Figure 2.5: SERS of cisplatin/transplatin bound to 30 bp ds-DNA SN5. (a) Spectra (i) before, 
(ii) immediately following, and (iii) after overnight incubation with cisplatin. (b) Same as (a) for 
transplatin. Spectra are offset for clarity. Inset: Spectral correlation functions r a,p for different 
DNA spectra as labeled. 
Representative SERS spectra of 30 bp dsDNA (SN5) on mercaptohexanol (MH) 
passivated nanoshell substrates before and after incubation with cisplatin and transplatin are 
obtained (Figure 2.5). (MH surface passivation is performed to prevent nonspecific binding of 
DNA and platinum ligands to the Au nanoshell surface, assuring better DNA-ligand 
interaction. 105) SERS spectra of DNA before and after incubation with cisplatin or transplatin are 
similar, with the only recognizable new peak at~ 450 cm-1, which can be attributed to the 
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1 .. hi 106 P atmum-amme stretc ng mode. The appearance of this new peak verifies covalent bonding 
of the cis-/transplatin to the DNA. 
Although the spectra clearly change over time, all the SERS spectra remain reasonably 
reproducible (r > 0.95), validating the cross-comparison of the SERS spectra between different 
samples. The reduction in SERS spectral reproducibility is explained by the binding of cisplatin 
and transplatin to DNA resulting in the formation of monofunctional, interstrand and intrastrand 
adducts. Since these adducts can form randomly at any purine residues, it is expected that 
random modifications ("kinks") in the molecular conformation of the DNA will increase 
significantly upon adduct formation. The increase in DNA distortion induced by cisplatin 
binding during incubation does indeed correlate with a decrease in spectral reproducibility 
(Figure 2.5.a). This observation is consistent with the current understanding of this interaction as 
a two-step process, where cisplatin initially attaches quickly and preferentially to the N7 atom of 
guanines and adenines, forming cisplatin/DNA monoadducts. Then, monoadducts are converted 
into bivalent platinum/DNA complexes in a much slower step that takes up to several hours107• In 
contrast, for transplatin, the spectral reproducibility appears time-independent, (Figure 2.5.b). 
consistent with the fact that transplatin/DNA interaction is a one-step process. 107 
It is also clear from our SCF analysis that the spectral changes induced by cisplatin (Pi,ii) 
= 0.85 immediately after adding cisplatin and pi,iii) = 0. 73 after overnight incubation) are much 
more significant than those induced by transplatin cr<i,ii) = 0.97 right after adding transplatin and 
pi,iii) = 0.97 after overnight incubation). The cross-linking of cisplatin to DNA is believed to be 
predominantly intrastrand, occurring between two adjacent purines (1,2 intrastrands, d(GpG) or 
d(ApG), -90%). 108 Other intrastrand linkages that may occur are between purines separated by 
one or more nucleotides, and interstrands between purines from opposite DNA strands. A few 
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adducts are likely to remain monofunctional. It is widely accepted that the 1,2 intrastrand adducts 
locally unwind and bend double stranded DNA. 109 This is consistent with our observation that 
cisplatin interaction induces numerous complex changes in the SERS spectrum and a decrease in 
rover time. In the case oftransplatin, some of the cross-links formed are interstrands, but most 
ofthe adducts remain monofunctional, inducing significantly less DNA distortion. This is 
consistent with our observation that r is unchanged upon DNA-transplatin incubation. 
These experiments demonstrate that SERS of DNA can detect ligand binding in two 
ways: by exciting the Stokes modes of the ligands themselves, but also through the complex 
conformational changes occurring in the DNA spectra resulting from the conformational 
distortion due to ligand binding. We believe that this SERS-based approach can be 
straightforwardly applied to studying the binding affinities of DNA with small molecules. This 
approach may also be used to develop a new type of all-optical chemical sensor based on optical 
detection ofDNA conformational changes upon binding ofthe DNA to a ligand of interest. 
2.5 Conclusion: 
This work demonstrates a successful method for obtaining high quality SERS spectra of 
single and double stranded DNA. Thermal uncoiling of ssDNA and hybridization of dsDNA 
dramatically increase the reproducibility of SERS spectra, acquired on nanoshell SERS 
substrates with highly regular, highly controlled electromagnetic enhancements. 
Regardless of the DNA composition, sequence and hybridization state, the SERS spectra 
of our model DNA exhibit almost identical spectral features dominated by adenine. The high 
spectral quality and reproducibility of the spectra strongly suggest the possibility of using 
adenine as an endogenous SERS reporter of DNA. High quality, highly reproducible DNA 
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spectra may also provide opportunities for label-free DNA detection schemes based on surface 
enhanced Raman spectroscopy. 
The study of the interaction of cis- and transplatin with ds-DNA reveals that spectral 
changes and reproducibility are highly correlated with DNA-cisplatin binding. These 
experiments demonstrate the possibility of using SERS to investigate the interaction and kinetics 
of DNA with various molecules, a topic of high-priority interest in drug discovery, 
pharmaceutical development and testing. 
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Chapter 3: Correlation of Molecular Orientation and Packing 
density in a dsDNA self-assembled monolayer observable with 
Surface Enhanced Raman Spectroscopy 
3.1 Introduction: 
DNA, the genetic material of most living systems, has more recently found its way into many 
novel applications ranging from nanoelectronics 110 to DNA-based nanosensors. 111 • 112 In these 
applications, the binding of DNA to metal surfaces, frequently through the use of a terminal 
functional group on a DNA oligomer, is prevalent. In particular, the orientation of DNA 
immobilized on Au surfaces has been extensively studied both experimentally113 and 
theoretically114• The ability to monitor the orientation of DNA molecules tethered to metal 
surfaces is crucial to improving these applications. It has been proposed that the orientation of 
DNA molecules bound to surfaces correlates with packing density, however, most of these 
studies were done in the context of determining the optimal packing density of ssDNA for 
maximum hybridization114• 115• Here we report that the surface-enhanced Raman spectra of a 
thiolated dsDNA monolayer provide a new level of detail regarding its orientation and packing 
density on an Au nanoshell surface. 
This chapter is an important extension of our previous work in which we demonstrated that a 
simple protocol based on thermally pretreating DNA prior to binding to Au nanoshell SERS 
substrates greatly enhances its spectral quality and reproducibility116• Here we use the same 
experimental procedure to investigate the orientation of dsDNA bound to the Au nanoshell 
surface. SERS is particularly advantageous for this study since the enhancement depends, in 
addition to other parameters, on the relative orientation of the investigated molecule with respect 
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to the substrate surface. However, only few attempts to study DNA orientation on gold surfaces 
using SERS have been reported 117• The high reproducibility of our DNA SERS spectra allows us 
to monitor variations in DNA orientation with respect to its packing density in significant detail. 
3.2 Results and Discussion: 
Our detection strategy is based on comparing the relative intensities of the Raman breathing 
mode of guanine at (667 cm-1) and the Raman ring-bending mode of adenine at (623 cm-1) 118 in 
the SERS spectrum of thiolated DNA bound to Au nanoshell surfaces. Adenine and guanine 
possess the highest Raman cross-sections of the naturally occurring DNA bases: SERS features 
from thymine and cytosine are much weaker, and are indiscernible in our experiments. For the 
Au nanoshells used in this study, the LsERs, defined as the effective 1/e distance for SERS above 
the nanoparticle surface, is ~ 9 nm/ 19 corresponding to ~30 bases for a vertical DNA 
conformation. The DNA sequences used in this study, SA20Nl and SA10Nl, were designed 
specifically with adenine in the first 20 and 10 bases closest to the Au surface, respectively. 
Oligonucleotide Sequence (5'-3') 
SA2oNl SH-C6-AAAAAAAAAAAAAAAAAAAACGCCGTTAGTCCA 
(70 bases) ACTGGCATGTAGTATCGTCCGATGCAACCAGCGTCAG 
SAlON I SH-C6-AAAAAAAAAAGCTGCTGTCCCGCCGTTAGTCCAAC 
(70 bases) TGGCATGTAGTATCGTCCGATGCAACCAGCGTCAG 
Table 3.1: DNA sequences used in the described experiments 
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As a result, for DNA in a near-vertical orientation, the adenine peak has a significantly higher 
intensity relative to the guanine peak. As the DNA tilt angle increases, more guanine bases enter 
the fringing field (Figure 3.1.A). Thus the guanine peak intensity gradually increases relative to 
the adenine peak. The ratio of the guanine to the adenine peak intensity can be correlated 
quantitatively with an effective tilt angle for the DNA. For simplicity, we will call RGtA the ratio 
of the intensity of the 667 cm-1 guanine peak to the 623 cm-1 adenine peak. 
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Figure 3.1: SERS detection of DNA orientation. A) schematic of the orientation detection 
strategy based on variation of dsDNA tilt angle. B) SERS spectra of SA20Nl with its 
complement at different DNA concentrations. Spectra 1 to 5 correspond to 40, 20, 10, 5 and 1.25 
jlM dsDNA, respectively. Spectra are offset for clarity 
Figure 3.1.B shows the SERS spectra of dsDNA (SA20N1 with its complement) at different 
DNA concentrations. For the sample at high DNA concentration, corresponding to a high 
packing density, the adenine peak intensity is much greater than the guanine peak intensity. The 
DNA surface density was not directly calculated; however, it could be roughly estimated to be 
around 18 pmol/cm2 at high surface coverage regime120• This appears to correspond to a 
minimum tilt angle. On the other hand, at low DNA concentrations corresponding to low packing 
densities, the guanine peak intensity significantly increases relative to the adenine peak intensity, 
suggesting a tilted DNA conformation. These observations are consistent with previous work 
suggesting that DNA chains tend to stand up at high packing density and lie down at low packing 
To better illustrate the correlation between DNA orientation and packing density for SA20N1, 
we plotted Ra1A against DNA concentration (Figure 3.2). Ra1A decays asymptotically with 
increased DNA concentration. This same experiment was also performed with 70 bp DNA with 
the same sequence as SA20N1 but with 10 adenine (thymine) bases adjacent to the terminal thiol 
group (and complement) (Figure 3.2). 
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Figure 3.2: Guanine to adenine peak intensity ratio as a function of DNA concentration. Blue 
and red lines correspond to SA20Nl and SA10Nl, respectively, conjugated with their 
complementary sequences. Insets show schematics of variations of DNA orientation with 
packing density. 
The highly systematic variation of Ra;A with DNA concentration strongly suggests that 
guanine and adenine are changing their relative proximities to the Au surface. Since 70 bp 
dsDNA is likely to adopt a rigid rodlike structure 121 , these measurements are consistent with a 
variation of the DNA orientation on the Au surface. As a control, we plotted the ratio of the 
intensity of the ring-bending mode of adenine at (623 cm-1) to the intensity of the breathing mode 
of adenine at (736 cm-1) as a function of DNA concentration. As would be expected, this ratio 
was observed to be constant since the two peaks belong to the same DNA base (Figure 3.3) 
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Figure 3.3: The ratio of the intensity of the ring-bending mode of adenine at 623 cm-1 to the 
intensity of the breathing mode of adenine at 736 cm-1 as a function of the DNA concentration. 
The highly consistent trends in the variation of RGIA with concentration for the two DNA 
sequences demonstrates a strong likely correlation between DNA packing density on the Au 
surface and DNA chain orientation (avg. tilt angle). It also suggests that RG/A may be useful as a 
noninvasive optical monitor to assess packing density ofthiolated DNA chains on a SERS-active 
Au substrate in sensing applications. 
Both RG/A plots in Figure 3.2 show dramatic increases at low DNA concentrations, 
corresponding to DNA chains in close proximity to the Au surface. The asymptotic case would 
occur for nonthiolated dsDNA lying on the Au surface. For the nonthiolated case, the RG/A value 
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was found to be much higher than the values measured here for thiolated dsDNA (6.9 compared 
to ~3, Figure 3.4). 
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Figure 3.4: SERS spectrum ofnonthiolated SA20Nl with its complement 
To test the validity of the proposed model, we investigated the possibility of varying the DNA 
orientation by coadsorbing additional, smaller molecules to the Au surface that would "lift" the 
DNA chains off the substrate surface. Short thiolated polyT (20 bases) was chosen as a 
"molecular spacer" for several reasons: its SERS signal is indetectable and would not contribute 
to the spectrum; it also binds to Au surfaces via its thiol moiety, and it has minimal affinity with 
the dsDNA, so it is not likely to induce conformational variations in the dsDNA itself. 
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Figure 3.5 shows a dramatic decrease in RG/A when polyT is coadsorbed with the thiolated 
dsDNA, (see supporting information for experimental details) corresponding to a decrease in tilt 
angle due solely to the presence of the coadsorbed molecule. With the polyT bound to the Au 
surface, the available space for the long DNA chains decreases, causing them to adjust their 
spatial orientation to a more upright conformation. 
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Figure 3.5: DNA tilt due to incubation with polyT. (a) SERS spectra of SA20Nl(2.5 J.!M) before 
polyT incubation, (b) SERS spectra of SA20Nl after polyT incubation, (c) bar plot showing the 
adenine guanine peak intensity ratio before and after polyT incubation. Insets are schematics 
depicting the DNA orientation variation caused by polyT incubation. 
3.3 Conclusions: 
In summary, we have observed that the ratio of two specific features in the SERS spectrum of 
adenine and guanine in thiolated dsDNA provide highly consistent markers that correlate with 
DNA chain orientation with respect to the substrate surface. From this analysis, DNA appears to 
adopt a steeper orientation at higher packing densities, which for decreased packing densities is 
51 
reduced. This study will shed light on geometric structure of long chain molecules in general 
and particularly DNA bound on metal surfaces. Understanding the way this geometrical structure 
depends on the molecular surface coverage would have great benefit on many technology based 
on surface chemistry. 
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Chapter 4: Label-Free Detection of DNA Hybridization Using 
Surface Enhanced Raman Spectroscopy 
4.1 Introduction: 
Recently, DNA hybridization has become one of the most frequent applied techniques for 
clinical laboratory screening of genetic and infectious diseases as well as for forensic testing. 122-
124 In a typical DNA hybridization design, probe DNA must be labeled with a radioactive or 
optical label for detection. The most common DNA array technique employs fluorescent 
labels125• 126, which, unfortunately, is both chemically and labor intensive. Also, its quantization 
accuracy is often compromised by the poor photostability of the labeling fluorophores. 
Significant progress has been made in the development of alternative DNA assay techniques 
by using gold nanoparticles,127' 128 dye-doped silica nanoparticles129, and quantum-dots130• 131 as 
optical tags combined with various modalities of optical detection schemes. Although these 
approaches have the potential to improve the detection limits, they too, involve costly tagging 
chemicals and detection instrumentation. On the other hand, label-free detection has been 
emerging as a potential method for detecting DNA hybridization at high sensitivity with low cost 
and less preparation time. Whereas several format for label-free detection have been proposed 
such as electronic132, colorimetric133• 134, and electrochemical135, surface enhanced Raman 
spectroscopic (SERS) has not been yet explored as a promising alternative to achieve this goal. 
The SERS detection of a single adenine base makes this technique ideal for ultrahigh sensitive 
label-free detection of DNA hybridization. 136 Most of the reported SERS-based DNA detection 
techniques are fundamentally based on detecting labels (SERS active tags) where the presence of 
the label is an indication of the presence of target DNA. 137-139 Two main impediments have 
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prevented the development of a label-free detection technique based on SERS. First, the spectral 
reproducibility has been a major challenge for SERS especially for biomolecules such as DNA. 
Recently, we have reported an experimental procedure based on thermal cycling DNA oligomers 
which greatly enhances DNA spectral quality and reproducibility140• Second, since both target 
and capture probe sequences (capture probe sequence is bound to the SERS-active substrate and 
complementary to the target sequence) are consisted of the same DNA bases, distinguishing 
SERS signal resulting from the hybridization of the target sequence is extremely challenging. 
Au nanoshells (Au NS), spherical core-shell nanoparticles consisting of a silica core and Au 
shell with plasmon resonance frequencies controlled by the relative inner and outer radius of the 
metallic shell layer, have been used as reproducible SERS substrates. 119• 141-143 In previous 
reports, we have proved that Au NS-based SERS-active substrates are ideal for large molecules 
detection such as DNA. 140' 144 By thermally cycling ssDNA, the spectral quality and 
reproducibility was greatly enhanced. All DNA sequences were proven to have similar SERS 
spectra dominated by adenine SERS features regardless sequence length and/or base 
composition. This step is considered a major achievement towards SERS-based DNA label-free 
detection technique. 
In this chapter I will discuss how we developed a label-free detection technique based on 
highly reproducible DNA SERS spectra on NS substrates and a substitution of all adenine bases 
on the capture probe sequence with the artificial base analogue 2-aminopurine. The 2-
aminopurine substitution allows for the detection of target hybridization based on the appearance 
of the dominant SERS peak of adenine bases located within the target sequence. This is the first 
reported SERS-based label-free DNA detection technique based on DNA base substitution. 
54 
4.2 Experimental: 
Nanoshell-based SERS substrates consisting of dispersed nanoshells bound to glass substrates 
were prepared as previously described. 145• 146 Briefly, a fused quartz microscope slide (Piranha 
cleaned) was incubated overnight in an (1 %) ethanolic solution ofpoly(4-vinylpyridine) (MW = 
160 000 from Sigma-Aldrich) and dried with nitrogen gas; subsequently, 100 ,uL of aqueous 
nanoshell suspension was deposited onto the substrate. The substrate was then allowed to sit at 
room temperature for 3-4 h before being rinsed with Milli-Q water Millipore, Billerica, MA) to 
remove excess nanoshells and then dried with a gentle flow of nitrogen. 
All DNA sequences (Table 4.1) were purchased from Integrated DNA Technology Inc. 
(Coralville, lA). Prior to use, all thiolated DNA oligomers were reduced with 1,4-dithio-DL-
threitol (Fluka) and purified with NAP5 purification columns (GE Healthcare). Unthiolated DNA 
sequences were used as received, having been HPLC-purified by the vendor. DNA uncoiling was 
achieved in solution, prior to binding of the DNA to the substrate by heating the DNA solutions 
in TE buffer (1x Tris EDTA buffer, pH) 7.5, from IDT) to 95 oc for 10-15 min. This step was 
followed by rapid cooling in an ice bath. DNA prehybridization was carried out ex situ by 
mixing two complementary DNA sequences at a 1: 1 molar ratio in DNA hybridization buffer 
(TE/50 mM NaCl, pH= 7.5), heating the solution to 95 °C, and then allowing it to cool slowly to 
room temperature in a large water bath. To bind DNA to the nanoshell SERS substrates, 50 ,uL 
(typically 40 ,uM) of the target DNA (ssDNA/dsDNA) was deposited onto a freshly made 
nanoshell SERS substrate. After overnight incubation, the excess ssDNA or dsDNA solution was 
removed by rinsing with TE or TE/50 mM NaCl buffer, respectively. In-situ hybridization was 
performed by adding 50 JlL of the eDNA, corresponding to 1: 1 molar ratio, to a SERS substrate 
that was previously functionalized with thio1ated ssDNA, followed by adding 50 JlL of 
55 
hybridization buffer. After overnight incubation, the excess ssDNA solution was removed by 
rinsing with TE/50 mM NaCl. 
Oligonucleotide 
SN3 
C-SN3 
SN4 
S2APN5 
C-S2APN5 
SN6 
Sequence (5'-3') 
SH-C6-TTTTTTTTTTTTTTTTTTTTGCGGCAATCAGGTT 
GACCGTACATCATAGCAGGCTAGGTTGGTCGCAGTC 
SH-C6-TTTTTTTTTTTTTTTTTTTTGCGGCTTTCTGGTT 
GTCCGTTCTTCTTTGCTGGCTTGGTTGGTCGCTGTC 
SH-C6-TCTTGCTGTGTCTGTTCTTT 
AAAGAACAGACACAGCAAGA 
CATGTGACCTCTTCTAGATC 
SH-C6-CGCT/2AP/GG/2AP/TCTG/2AP/CTGCGGCTCCTC 
C/2AP/T 
ATGGAGGAGCCGCAGTCAGATCCTAGCG 
CATGTGACCTCTTCTAGATC 
Table 4.1: Oligonucleotide sequences used in the described experiments 
SERS spectra were recorded while substrates were immersed in the appropriate buffer (TE for 
ssDNA and TE/50 mM NaCl for dsDNA) by using a Renishaw in Via Raman microscope 
(Renishaw, U.K.) with 785 nm excitation wavelength. Backscattered light was collected using a 
63 x water immersion lens (Leitz, Germany), corresponding to a rectangular sampling area of 3 
pm x 30 pm. Unless stated otherwise, all the SERS spectra in this work were obtained with an 
integration time of 20 s and a laser power of 0.57 m W before the objective. 
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4.3 Results and Discussion: 
4.3.1 Label-Free Detection Using Adenine-Free Capture Probe: 
All SERS spectra are averages of at least 8 spectra acquired from different spots of the same 
substrate to ensure SERS spectral reproducibility. Typical r 140 (spectral correlation function) of 
~ 1 is calculated for all SERS spectra. The overwhelming dominance of adenine spectral features 
is supported by previous studies and is primarily attributed to the higher SERS cross section of 
adenine. 136 The DNA SERS spectrum looks extremely similar to adenine SERS spectrum, 
dominated by the 736 cm-1 peak (adenine breathing mode) (Figure 4.l.a). In the presence of 
adenine, spectral features from other DNA bases (guanine, thymine and cytosine) are 
inconsequential. SERS of adenine-free DNA, DNA sequence that does not contain adenine bases 
(ST20N2), shows SERS modes of other bases especially guanine (Figure 4.1.b). The main SERS 
feature of the adenine-free DNA spectrum appeared at 663 cm-1 (guanine breathing mode). 
57 
400 800 1200 1 1600 
Raman Shift (em ) 
Figure 4.1: SERS of DNA sequences (a) with adenine bases and (b) with no adenine bases 
I Peak Assignment 
663 G breathing mode 
958 NH bending 
1349 A and G stretching 
1449 A and G stretching 
1705 Carbonyl group 
Table 4.2: Raman Assignments 
This result proves that the overwhelming 736 cm- 1 mode is very distinctive for adenine bases. 
This 736 cm-1 strong adenine SERS mode can be used to detect the presence of a target sequence 
(containing adenine) that would hybridize to a capture probe which is adenine free. The SERS of 
the adenine-free capture probe is missing the 736 cm-1 mode as shown in Figure 4.l.b. 
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In the adenine-free capture probe format, single stranded adenine-free DNA sequences 
(capture strand) were first immobilized on the Au NS SERS active substrate through a thiol 
moiety on their 5' end, the rest of the DNA sequences are available for hybridizing with the 
complementary strands. SERS of the capture probe sequences is shown in Figure 2 with the main 
peak being at 663 cm-1 (guanine breathing mode). A target sequence (complementary to the 
capture probe) and a random sequence (non-complementary to the capture probe) were 
separately hybridized with the capture probe. The hybridization of the target sequence is evident 
by the appearance of the 736 cm-1 adenine peak (Figure 4.2.a). For the control sequence, a very 
small peak appeared at 736 cm-1 due to DNA/DNA interaction as well as DNA/surface non-
specific binding (Figure 4.2.b). 
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c 663 
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Figure 4.2: SERS label-free detection of DNA hybridization based on adenine-free probe. SERS 
of: (a) capture probe hybridized with complementary DNA sequence (target), (b) capture probe 
hybridized with non-complementary DNA sequence (control) and (c) DNA capture probe 
(adenine-free) 
It has been reported that, for on-surface DNA hybridization, the packing density of the capture 
probe greatly affects the hybridization efficiency96 • Lower capture probe packing density 
significantly increases the hybridization efficiency since it allows for better interaction between 
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the capture probe and the DNA target. On the other hand, lower packing density provides more 
free space between DNA probe sequences for DNNsurface non-specific binding. This non-
specific binding is significant for Au surfaces due to the high affinity between single stranded 
DNA and Au. To overcome this problem, mercaptohexanol was used to passivate the free 
surface which prevents target single stranded DNA from interacting with the Au surface. 
Label-free detection of DNA hybridization has been proven using SERS and adenine as a 
SERS biomarker. Since the hybridization is indicated by the appearance of the main adenine 
peak, the capture strand has to be adenine-free. A convolution of adenine spectral features from 
capture and target DNA sequences is undesirable. Whereas this result is very promising, 
limitation in the detected DNA sequences is very unpractical. 
4.3.2 Label-Free Detection Using 2-Aminopurine Substituted Capture Probe 
To overcome the problem of sequence limitation substitution of adenine bases in the capture 
probe rather than completely eliminating them has been considered. 2-aminopurine have been 
found to be widely used as an artificial adenine substitution.147 The substitution of adenine by its 
isomer 2-aminopurine, preserves the same characteristics of the substituted sequence. Very 
similar to adenine, 2-aminopurine binds to thymine through hydrogen bonding. 148• 149 The 
substitution only causes a very small perturbation of the nucleic acid structure. 150 
The SERS of the 2-aminopurine bases, however, is quite different than adenine bases. Most 
importantly, 2-aminopurine does not have SERS features at 736 cm-1 region (Figure 4.3.a) which 
means that it can be used as an ideal adenine substitution. SERS of DNA sequence containing 2-
aminopurine shows only two main features at 807 cm-1 (breathing mode of 2-aminopurine) and 
663 cm-1 (breathing mode of guanine) (Figure 4.3.b). A 2-aminopurine substituted DNA capture 
61 
probe can be used as a label-free adenine-based detection system where the hybridization of the 
target sequence is marked by the 736 cm-1 adenine peak. 
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Figure 4.3: Raman spectroscopy of 2-aminopurine. (a) Surface enhanced (black) and non-
enhanced (red) Raman spectroscopy of 2-aminopurine bases. (b) SERS of DNA containing 2-
aminopurine bases. All adenine bases are substituted with 2-aminopurine. Inset is structural 
formula of 2-aminopurine. 
Figure 4.4 shows the SERS spectra of the target (a) and a non-complementary control (b) 
DNA sequences hybridized to the 2-aminopurine substituted capture probe. The hybridization of 
the target sequence is identified by the 736 cm-1 adenine peak. 
Further spectral proof of the target sequence hybridization, in addition to the 736 cm- 1 adenine 
peak, is demonstrated by comparing the intensity of the guanine peak (663 cm-1):2-aminopurine 
peak (807 cm-1) ratio between the target and the non-complementary control sequence. A 
significant increase of this ratio is observed in the case of target hybridization. A relative 
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increase in intensity of the guanine peak indicates the hybridization of the target sequence, which 
contains guanine bases. The hybridization of the target sequence is verified by the appearance of 
a new peak at 736 cm-1 (adenine peak) and the relative increase of the guanine peak. 
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Figure 4.4: Label-free detection of DNA hybridization based on 2-aminopurine modified DNA 
probe. (a) complementary DNA sequence hybridized to 2-aminopurine probe (target). (b) non-
complementary DNA sequence hybridized to 2-aminopurine probe (control). 
4.3.3 Hybridization Efficiency: 
On-surface DNA hybridization has been extensively studied for different surfaces, capture 
probe sequences and packing densities, buffers and so on. Experimentally determining the DNA 
hybridization is a very time consuming task. It usually requires dye-labeling the target sequence 
and determining the number of hybridized DNA sequences after displacing the DNA target and 
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capture probe from surface96• Since the fluorescence of these label dyes is very pH dependent, 
keeping experimental solutions at the optimum buffer conditions (pH and salt concentration) for 
dye fluorescence is tedious, difficult and typically introduces some experimental errors. 
The SERS label free detection technique described provides a more straightforward way to 
determine hybridization efficiency. The DNA hybridization efficiency can be simply calculated 
based on the ratio of the 736 cm-1 adenine peak intensity to the 807 cm-1 2-aminopurine peak 
intensity. The intensity of the 807 cm-1 2-aminopurine peak is constant and determined only 
based on the capture probe packing density. The peak ratio is 0 for non-hybridization. When 
capture probe and target sequences are prehybridized prior to binding to the NS substrate, the 
peak ratio would be maximum corresponding to A100% hybridization efficiency. Different 
hybridization efficiencies can be extrapolated from the different peak ratios and correlated to the 
target concentration. The hybridization efficiency is normalized for all substrates since it only 
depends on the ratio of intensities of the two peaks. 
Figure 4.5 shows that the hybridization efficiency is fairly low even at high target concentration 
( ~ 11% at 80 JlM). The low hybridization efficiency is consistent with previous reports96 and is 
mainly due to the capture probe packing density and hybridization conditions (buffer, 
temperature). Mercaptohexanol was used as a spacer molecule which increases the hybridization 
efficiency and decreases the non-specific DNNsurface interaction (result not shown). In 
addition, it was suggested that using a spacer short DNA sequence could further improve the 
hybridization efficiency. 96 
This system provides a straightforward approach to study DNA hybridization efficiency for 
different DNA sequences, buffer conditions, spacers and so on. This could help improve other 
DNA detection techniques as well as on on-surface DNA hybridization technologies 
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Figure 4.5: Label-free detection calibration curve. Plot shows the hybridization efficiency versus 
target concentration 
In addition, since, the DNA mutations decrease the hybridization efficiency, 132 this technique 
can be used to detect DNA mutations such as SNP (single nucleotide polymorphism). 
Introducing a mutation on the target sequence should decrease the hybridization efficiency which 
can be determined as a decrease in the peak ratio. Moreover, chemically modified DNA 
(oxidized or methylated) should also have a lower hybridization efficiency which could be 
detected as well. Particularly, DNA oxidation, which occurs most readily at guanine and 
correlated to aging-related diseases such as cancer could be detected. SERS of oxidized guanine 
will be different than normal guanine. The presence of oxidized guanine on the target sequence 
can be indicated by: (i) decrease in the adenine to 2-aminopurine peak ratio due to lower 
hybridization efficiency associated with sequence perturbation. (ii) decrease in the guanine to 2-
aminopurine peak ratio since oxidized guanine will not have the same SERS features as native 
guanine. (iii) possibility of the appearance of new SERS features associated with the oxidized 
guanine. 
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One advantage of using SERS for DNA detection is the tremendous amount of information 
that could be derived from the SERS spectra. Whereas other DNA detection techniques are based 
on detecting tags, our detection scheme is based on detecting DNA itself. As a result the slightest 
variation on DNA target base composition and/or chemical structure can be easily detected. This 
technique can be extended beyond simple DNA detection to detecting mutated and chemically 
modified DNA, which could be used for many biomedical applications. 
4.3.4 Target Concentration and Detection Limits: 
The system allows measurement of the target concentration based on the calibration curve 
(Figuer 4.5). Whereas in other DNA detection techniques, target concentration is typically 
determined through a comparative study, in this system, target sequence concentration could be 
directly extrapolated from the calibration curve. The adenine to 2-aminopurine peak intensity 
ratio is directly correlated to the target concentration. We have reported that thermal relaxation 
of DNA provides high substrate to substrate SERS spectral reproducibility in terms of peak 
position but not peak intensity. In SERS, peak intensity depends not only on number, 
conformation and relative proximity of molecules to the surface, but mostly on substrate quality. 
Comparing intensities of spectra acquired on different substrates requires high substrate 
reproducibility which is experimentally hard to achieve. The described label-free detection 
technique allows substrate to substrate comparison since it is based on the peak ratio regardless 
of the absolute intensity. The peak ratio depends only on the number of target molecules with 
respect to the number of probe molecules which represent the hybridization efficiency. 
To determine the detection limit of the SERS label-free detection technique, we performed the 
hybridization experiment with decreasing DNA target concentrations. SERS of different samples 
was then acquired. Data shows that the minimum target concentration that could be detected and 
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discriminated versus a control sequence based on the peak ratios is ~80 nM corresponding to 
only 1.2 x 106 detected DNA molecules. 1.2 x 106 is the number of molecules on the 30 f.!m x 3 
f.!m sampling area and it is based on the DNA surface coverage (determined based on previous 
reports 151 ) and DNA hybridization efficiency. It is worth to note that for 80 nM target 
concentration, the hybridization efficiency is only 0.3 %, this value could be easily improved by 
developing appropriate hybridization buffer and/or altering the capture strand packing density. 
The detection limit for the described technique is not determined by the target concentration 
rather by the hybridization efficiency, increasing the hybridization efficiency to 30 % will 
decrease the detection limit to the femto molar range. 
The packing density of single stranded DNA on a Au surface which is easily predicted from 
previous studies is related to the number of hybridized DNA molecules through the hybridization 
efficiency. This technique is able to determine the absolute number of DNA molecules 
hybridized to the substrate which is relevant to all biomedical applications involving DNA 
detection. Number of molecules detected is reported for different target DNA concentration in 
Figure 4.5. 
4.4: Conclusion 
We observe that adenine can be used as a Raman marker for detecting DNA hybridization. 
The SERS high sensitivity to adenine bases (single molecule detection) makes adenine an 
optimum marker for label-free detection of DNA hybridization. We showed that an adenine-free 
DNA sequence can be used as a capture probe to label-free detect DNA hybridization. The 
appearance of the adenine peak is an evidence of the target hybridization. To overcome the 
limitation on detecting only thymine-free DNA, we substituted all adenine bases with 2-
aminopurine bases. Whereas 2-aminopurine is chemically similar to adenine, SERS signal of 2-
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aminopurine is quite different. Most importantly 2-aminopurine does not have any SERS feature 
at 736 cm-1 (breathing mode of adenine). The appearance of the adenine peak is still distinctive 
to the hybridization of the target sequence. Since the ratio of the adenine peak to the 2-
aminopurine peak depends only on the number of the target sequences with respect to the 
number of the probe sequences, this technique can be used to determine both hybridization 
efficiency and target concentration. The high sensitivity to the hybridization efficiency allows 
the technique to be extended to detect DNA mutation such as SNP (single nucleotide 
polymorphism) and DNA base modification such as oxidation and methylation which will all 
decrease DNA hybridization efficiency. The detection limit is demonstrated to be ~80 nM which 
corresponds to only 1.2 x 106 DNA molecules under SERS sampling area. Given that the 
detection of a single adenine base is attainable by SERS, ultra sensitive label-free detection 
technique based on SERS is approachable by experimentally improving the hybridization 
efficiency. 
68 
Chapter 5: Detecting Chemically Modified DNA Bases Using 
Surface Enhanced Raman Spectroscopy 
5.1 Introduction: 
The chemical modification of DNA bases has become a topic of rapidly increasing interest in 
the assessment of human disease. There are two major types of DNA base chemical 
modifications of interest in this context. The first occurs in epigenetics, the study of alterations in 
gene expression induced by changes other than modifications in the genetic code. Chemically 
modified bases can alter phenotype without changing DNA sequence. 152 Epigenetic markers are 
thought to arise due to the influence of environmental factors influential in the onset of diseases 
such as cancer. In eukaryotic cells, methylated cytosine (mC) is the most common epigenetic 
marker. 153 In addition to its role in controlling gene expression, DNA methylation has been 
shown to strongly correlate with cancer in humans. Hypomethylation of DNA in human 
tumors, 154 hypermethylation of tumor-suppressor genes155' 156 and the inactivation of microRNA 
genes by DNA methylation 157 are all strong evidentiary factors of a relationship between the 
presence of chemically modified DNA bases and various human cancers. 
Hydroxymethylcytosine (hmC) is a stable DNA modification of great interest as a new 
epigenetic marker that has recently been discovered158' 159• Hmc is highly abundant in the brain 
and believed to be important in neuronal function. It is currently accepted that hmC performs a 
fundamentally different epigenetic function than mC, making discrimination between hmC and 
mC extremely important; however, distinguishing hmC from mC is very challenging. Common 
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methods such as enzymatic approaches and busilfite sequencing have proven unable to 
distinguish mC from hmC in DNA160• 
A second type of chemically modified DNA that is also extremely important is oxidized DNA. 
DNA oxidation occurs as a result of the interaction of reactive species of oxygen or nitrogen with 
genomic DNA161 • The most common form of DNA oxidation in eukaryotes is guanine 
oxidation162, resulting most commonly in G toT transverse mutation163• Despite the absence of a 
firm correlation between guanine oxidation and cancer, there is strong evidence that the level of 
guanine oxidation in genomic DNA is a relevant biomarker for assessing antioxidant status and 
cancer risk164. 
Typical methods for detecting DNA base modifications include single cell gel electrophoresis 
assay164 for guanine oxidation detection, and bisulfite-based 165•166• 167 or enrichment-based 
methods 166' 167 for DNA methylation. All these methods require multiple-step sample preparation 
with chemicals that may induce additional chemical modifications in the DNA or interfere with 
the detection of modified DNA. In addition, most of these methods fail to distinguish between 
hmC and mC. The low throughput of these methods makes them unreliable strategies for the 
development of clinical diagnostic assays. Therefore the need for robust, streamlined methods 
for detecting chemically modified DNA bases is an important goal for analytical research, with 
the promise of clinical applications and technological impact. 
Surface enhanced Raman spectroscopy (SERS) has been extensively explored to detect 
different types of biomolecules using broad range of nanostructures168-171 • In particular, Au 
nanoshells have shown great success as an active SERS substrate172-174• In this chapter, I report a 
simple and direct method for detecting the DNA base chemical modifications of adenine and 
cytosine methylation and hydroxymethylation, and guanine oxidation, using SERS. This method 
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is based on identifying SERS spectral variations due to DNA base modifications. No chemical 
treatments are needed, which eliminates the interaction of DNA with other chemicals, 
minimizing unwanted chemical modifications due to sample preparation. Applying this method 
would make detection of DNA base modification straightforward. 
5.2 Experimental and Methods: 
All DNA sequences used in this study were custom synthesized (Integrated DNA Technology, 
Inc). Modified bases were inserted during the sequence synthesis such that the number and 
position of modified bases was well determined. All DNA sequences were only thermally 
pretreated 172 before SERS spectral acquisition with no further chemical treatment. All SERS 
spectra shown are the average of at least 5 individual spectra acquired from different spots on the 
same substrate. All SERS spectra are highly reproducible, with a spectral correlation function (r) 
close to 1. 172' 175 
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5.3: Results and Discussion: 
5.3.1 Detection o(Methylated Adenine: 
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Figure 5.1: SERS spectra of (a) normal DNA sequence, and (b) adenine-methylated DNA 
sequence. Inset: molecular structures of adenine (top) and 6-methyladenine (bottom). 
The spectrum of thermally pretreated 12 base single stranded DNA sequences 
(TCAAGCTGTGAC) is shown in Figure 5.1.a. As expected, the SERS spectrum is dominated 
by the 736 cm- 1 peak (adenine breathing mode) 172• When all adenine bases are substituted by 6-
methyladenine (TCA *A *GCTGTGA *C) two new peaks appeared on the SERS spectrum, at 
1100 and 1197 cm-1 (Figure 5.1.b). The 625 cm-1 adenine peak disappears, and the 665 cm-1 peak 
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(guanine breathing mode) has higher intensity. The appearance of these two new peaks is a 
confirmative marker indicating the methylation of adenine bases. 
5.3.2 Detection o(Methyaled Cytosine: 
Cytosine methylation is the most abundant epigenetic marker in eukaryotes. Unfortunately, 
cytosine bases possess a significantly weak Raman cross section compared to adenine and 
guanine. 176 Cytosine SERS features can barely be distinguished in the DNA SERS spectrum. 
Therefore, it is expected that the methylation of cytosine bases would not introduce large spectral 
variations in the DNA spectrum. Figure 5.2 shows that the substitution of cytosine by 5-
methylcytosine (TC* AAGC*TGTGAC*) causes a slight increase in the 786 cm-1 intensity 
(cytosine breathing mode). 
Cytosine methylation of many eukaryotes frequently occurs at the CpG nucleotide sequences 
and 60 to 90% of all CpGs in mammals are methylated177' 178• Given this high degree of cytosine 
methylation, mC SERS detection is still possible although changes in the SERS DNA spectrum 
of this base are relatively minor. 
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Figure 5.2: SERS spectra of (a) normal DNA sequence, and (b) cytosine-methylated DNA 
sequence. Inset: molecular structures of cytosine (top) and 5-methylcytosine (bottom). 
5.3.3 Detection o(hydroxymethvlated Cytosine: 
In contrast, however, the hydroxymethylation of cytosine introduces a significant change in 
the DNA SERS specrum. It is worth noting that this particular DNA sequence has only one hmC 
due to synthesis limitations (TGAC* AGTTGTGATAG). Figure 5.3.b shows a significant 
intensity increase of the 665 cm-1 mode as well as the 963 cm-1 feature. Most importantly, the 
1397 cm- 1 is greatly suppressed as a result of the presence of the hmc base in the DNA sequence. 
The spectral variations between normal DNA and hydroxymethylated DNA are significant and 
dramatic, making verification of the presence of hmCs in a DNA sequence using SERS very 
straightforward. This data clearly indicates that a discrimination between mC and hmC is 
possible using SERS. The significant increase of the 665 cm-1 peak is an obvious marker of the 
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presence of hmC. The relative increase of the 786 cm-1 peak intensity for cytosine methylated 
DNA is still larger than the same peak increase for hydroxymethylated cytosine, rendering the 
detection of mC in the presence of hmC possible as well. To better elucidate this specific 
detection problem would require a DNA sequence containing both modifications. 
a t NH1 
: 0;__) 
-:::J 
m 
_.. 
>. 
-+-' 
·oo b 
' !; c Q) I -+-' ~ c 
' 
400 800 1200 1600 
Raman Shift (cm-1 ) 
Figure 5.3: SERS spectra of (a) normal DNA sequence, and (b) cytosine-hydroxymethylated 
DNA sequence. Inset: molecular structures of (top) cytosine, (bottom) 5-
hydroxymethylcytosine. 
5.3.4 Detection of Oxidized Guanine: 
The SERS spectrum of guanine oxidized DNA (where all guanine bases are substituted with 8-
oxo-guanine, (TCAAG*CTG*TG* AC) was acquired (Figure 5.4). Here there are two significant 
markers indicating guanine oxidation: the appearance of a new mode at 1079 cm-1 and the 
disappearance of the guanine breathing mode (665 cm-1). More detailed experimental studies 
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coupled with theoretical analysis are needed to identify the specific structural origin of these 
observed changes in the SERS spectrum. It is possible that the presence of modified DNA bases 
may affect the overall DNA spectrum by introducing new modes as well as suppressing or 
enhancing existing modes related the modified base itself. Also, modified bases may affect the 
DNA/ surface interaction causing enhancement and/or suppression of modes not related to the 
modified base itself. The scope of this study is limited to the experimental demonstration of 
SERS detection and the identification of spectral markers for specific DNA base modifications. 
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Figure 5.4: SERS spectra of (a) normal DNA sequence, and (b) guanine-oxidized DNA 
sequence. Inset: molecular structures of guanine (top) and 8-oxo-guanine (bottom). 
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5.4 Conclusion: 
In conclusion, we demonstrated that SERS can be used to identify chemically modified DNA 
bases, including methylated adenine, methylated and hydroxymethylated cytosine, and oxidized 
guanine. All identified markers are unique and evident for discrimination of the specific 
modification. No chemical pretreatment was used, maintaining the integrity of the DNA 
sequence and making this a potentially promising approach for diagnostic applications. 
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Chapter 6: Light-induced Release of DNA from Plasmon-resonant 
Nanoparticles: Towards Light-controlled Gene Therapy 
6.1 Introduction: 
Recently, many reported results proving the potential role of nanoparticles in therapeutic 
molecules delivery and controlled release. That is an excellent motivation for quantitative studies 
of the light-induced release process of DNA from plasmon-resonant nanoparticle surfaces. In 
this chapter we develop a Au-nanoparticle-based nonviral vector for antisense gene delivery 
consisting of double stranded DNA (dsDNA) covalently attached to NIR-absorbing, plasmon-
resonant Au nanoshells. Light-controlled release of ssDNA from Au nanoshells induced by 
resonant light absorption is demonstrated for oligonucleotide sequences of differing lengths and 
base compositions. The dehybridization temperatures of these sequences have been determined 
experimentally for both thermal and light-controlled dehybridization. Light-controlled 
oligonucleotide release is found to occur with essentially no temperature increase of the 
nanoparticle solution ambient, in stark contrast to thermal release, which occurs significantly at 
higher temperatures. Both dehybridization temperatures are found to be significantly below the 
solution-phase T m for the same oligonucleotide. The maximum dsDNA coverage, as well as the 
percentage of DNA released from the nanoparticle surface, are determined for both light-
controlled and thermal DNA dehybridization, and are found to be quite different for these 
processes. This work is the first study quantifying the effects of light-controlled DNA release 
from plasmon-resonant nanoparticles relative to thermally driven DNA release: the 
characteristics observed here are likely to provide general insight and stimulus for further study 
oflight-induced DNA release from other plasmonic nanoparticles. 
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6.1.1 Gold Nanos hells in Photothermal Therapy and Drug Delivery: 
Au nanoshells are spherical core-shell nanoparticles consisting of a silica core and Au shell 
with plasmon resonance frequencies controlled by the relative inner and outer radius of the 
metallic shelllayer.38' 39' 179 Au nanoshells can be designed to have their maximum absorbance in 
the NIR region of the spectrum. 180 This absorbance wavelength is particularly important for 
biomedical applications since it falls within the near infrared spectral water window where tissue 
is nearly transparent. When illuminated with NIR light of resonant wavelength Au nanoshells 
absorb a portion of the total electromagnetic energy incident on the nanoparticle complex and 
convert the light into heat, resulting in an increased temperature on the Au nanoshell surface. 
This nanoparticle-based light-to-heat conversion has been explored in other therapeutic 
applications, in particular for photothermal cancer therapy. 181 In this chapter, we study both 
purely thermal and light-controlled DNA dehybridization for DNA bound to nanoshell surfaces. 
The dsDNA has two strands: [1] a sense oligonucleotide with a thiol group on its 5' end for 
covalent bonding to the Au nanoshell surface, and [2] a complementary antisense 
oligonucleotide, which is the therapeutic sequence. These two complementary oligonucleotides 
hybridize through Watson-Crick base pairing. In this study, the therapeutic payload is the 
antisense oligonucleotide (ssDNA), and the principle is the same as antisense oligonucleotide 
therapy except Au nanoshells are the therapeutic carriers and light excitation controls the ssDNA 
release. Figure 6.1 shows a schematic of the Au nanoshell-based delivery system. 
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Figure 6.1: Schematic of light-controlled release of ssDNA from Au nanoshells. Green 
sequences are the thiolated sense sequences bound to the Au nanoshell surface, red sequences are 
the antisense sequences, released when nanoshells are illuminated with NIR light at their 
plasmon resonant frequency. 
6.1.2 Thermal Dehybridization o(dsDNA: 
The temperature at which melting, or dehybridization, of double stranded DNA tn 
solution occurs is influenced by many factors, including composition and orientation of 
neighboring base pairs, sequence length, and salt concentration. For example, dsDNA with a 
higher percentage of Guanine-Cytosine (GC) pairs will have a higher melting temperature, 
because the GC pair compared to the Adenine-Tymine (AT) has greater stacking interactions and 
an additional third hydrogen bond. To predict the melting temperature of dsDNA in solution, the 
nearest neighbor (NN) model is used to determine nucleic acid stability based upon the 
composition and orientation of neighboring base pairs 182-186• The NN model is based largely on 
experimental work over more than two decades that provided precise measurements of 
thermodynamic parameters. 187- 193 These included specifically the binding free energy (AG), 
enthalpy (AH), and entropy (AS) for the 10 possible neighboring base pair combinations: 
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AA/TT, AT/TA, TA/AT, CA/GT, GT/CA, CT/GA, GA/CT, CG/GC, GC/CG, GG/CC. So, by 
knowing the composition of dsDNA, the predicted aG can be calculated by summing the aG 
values of each neighboring base pair plus a aG initiation value (aGint). 
(1) 
Similarly, aH and aS are calculated and used to predict the melting temperature (T m) of 
complementary oligonucleotides. The total oligonucleotide strand molar concentration (CT), and 
the theoretical aH and aS, are used: 
(2) 
where R is the gas constant (1.987 cal/K·mol). The salt concentration also plays a critical role in 
dsDNA melting temperature. The T m increases with increasing salt ion concentration due to the 
salt ions shielding the Coulombic repulsion between the negatively charged phosphate 
backbones of the oligonucletides. If the salt ion concentration is low, the shielding decreases, so 
the dsDNA becomes less stable and the T m decreases. There has been much debate whether the 
salt effect is sequence or length dependent; however, the most accurate empirical equation is a 
quadratic salt correction function that is sequence, composition, and length dependent. Because 
of this extensive research effort the T m of dsDNA in solution is considered to be a relatively 
straightforward-to-predict value. However, binding dsDNA to nanoparticle surfaces for either 
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thermal or light-induced release introduces a new local environment for the DNA molecules 
which dramatically modifies solution phase T m values. 
6.2 Experimental: 
6.2.1 Thermal and Light-driven DNA Release: 
To demonstrate thermal and light-controlled release of ssDNA, several DNA oligomers 
of varying lengths and compositions (purchased from Integrated DNA Technology Inc.) were 
utilized (Table 6.1). Prior to use, all thiolated DNA oligomers were reduced with 1,4-Dithio-DL-
threitol (DTT, Fluka) and purified with NAPS purification columns (GE Healthcare). 
Unthiolated DNA sequences were used as received, having been HPLC-purified by the vendor. 
DNA hybridization was performed by mixing two complementary DNA sequences in a 1: 1 
molar ratio in DNA hybridization buffer (TE/50mM NaCl, pH = 7 .5), heating the solution to 95 
oc, then allowing it to cool slowly to room temperature in a large water bath. To ensure the 
maximum surface dsDNA coverage on the nanoshells, excess hybridized dsDNA was incubated 
with an aqueous suspension of Au nanoshells for at least 8 hours. The dsDNA was first 
precipitated with ethanol to minimize salt concentration and avoid nanoshell aggregation. 
Oligonucleotide Sequence (5'-3') 
ST2oN1 CTGACGCTGGTTGCATCGGACGATACTACATGCCAGTTGGACTA 
(70 bases) ACGGCGGGACAGCAGCTTTTTTTTTT 
SN2 GCGGCAATCAGGTTGACCGTACATCATAGCAGGCTAGGTTGGTC 
(50 bases) GCAGTC 
82 
SN3 
TATGATCTGTCACAGCTTGATACTACTTCA 
(30 bases) 
SN4 
TATGATCTGTCACAGCTTGA 
(20 bases) 
SN3-comp 
TGAAGTAGTATCAAGCTGTGACAGATCATA 
(30 bases) 
Table 6.1: DNA sequences used in this study. The released sequences are shown: the capture 
sequences are complements of these sequences with a thiol on the 5' end to ensure binding to the 
Au nanoshell surface. Labeled-sequences are the same released sequences with fluorescein on 
the 5' end. 
Before the thermal or light-assisted dehybridization of dsDNA, the DNA/nanoshell mixture 
was centrifuged at least twice and resuspended in fresh buffer to remove excess free DNA in 
solution. Light-assisted release was performed as follows: 1 ml of nanoshells/DNA suspension 
was illuminated with a continuous wave laser (DioMed, A. = 800 nm, 1 W incident power). The 
temperature of the suspension (ambient temperature) was monitored with a thermocouple. For 
non-labeled DNA sequences, 1 mL aliquots were taken at different temperatures and run in a 3% 
agarose gel. For fluorescein-labeled DNA samples, fluorescence measurements of the 
supernatant were performed. For thermal dehybridization, DNA/nanoshell suspension was 
heated in a water bath. Similarly, aliquots were obtained and run in gel electrophoresis or 
checked for fluorescence intensity. 
6.2.2 DNA-nanoshell Coverage and Percentage Release: 
To quantify the number of oligonucleotides on the nanoshell surface, a 12 mM 
mercaptoethanol solution (Sigma Aldrich) was used as a DNA-displacing solution. 
Mercaptoethanol rapidly displaces hybridized surface-bound oligonucleotide via a thio1 
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exchange reaction. 194 This process is rapid and efficient because the oligonucleotide self-
assembled monolayer (SAM) cannot block access of the mercaptoethanol to the gold surface and 
mercaptoethanol forms a more tightly packed SAM due to its greater packing energy via Vander 
Waals forces than the DNA monolayer it displaces. 
First, a standard curve of fluorescein-labeled DNA fluorescence intensity versus DNA 
concentration was experimentally determined. The amount of DNA bound to the nanoshell 
surface in a sample was determined by taking a fluorescence measurement of the supernatant 
before the mercaptoethanol displacing solution was added (background fluorescence) and after 
24 hours incubation with mercaptoethanol. Subtraction of the background fluorescence allowed 
us to obtain a value for the amount of DNA displaced. Nanoshell concentration was determined 
by using the Beer-Lambert law, the extinction coefficient was determined by Mie theory. Finally, 
the amount of DNA per nanoshell was calculated. Since the antisense strand was tagged with 
fluorescein, the amount of DNA released was easily quantified. After thermal or light-driven 
release of DNA, the difference in fluorescence intensity was calculated and the percentage of 
DNA released was determined. In these experiments the displacing solution was not used. 
6.3 Results and Discussion: 
6.3 .1 DNA Dehybridization Irreversibility: 
The purpose of this study was to compare the amount of ssDNA released by light-
controlled and thermal dehybridization, and to obtain the effective DNA-ambient melting 
temperature for both processes. Dehybridization reversibility is a critical concern for these 
processes, since rehybridization of the released ssDNA back to the nanoparticle once the laser 
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irradiation has ceased, if it occurs to a significant extent, would greatly limit the effectiveness of 
this strategy for gene delivery. 
In the first experiment, a suspension of Au nanoshell/dsDNA (SN3 prehybridized with its 
thiolated complement) was prepared as described. The ssDNA antisense strand has a fluorescein 
label on its 5' end. The prepared nanoparticles were divided into two samples. For both samples, 
DNA dehybridization was thermally induced. In one sample, an excess of the nonthiolated SN3-
complement was added to solution. In the presence of the excess of the SN3-complement, the 
released SN3 DNA will preferentially hybridize to the excess SN3-complement in solution. For 
the other sample, no additional DNA was added to the solution. After thermal dehybridization of 
both samples under the same experimental conditions, the aliquots were centrifuged and the 
fluorescence intensity of the supernatant was measured. The released sequence was the only 
source of a fluorescence signal. If the released DNA rehybridizes with its complementary 
sequences left behind on the Au nanoshell surface, the amount of fluorescent DNA in solution 
will be significantly higher for the sample with the excess DNA complement in solution and a 
measureably lower fluorescent signal when no SN3-complement is available in solution for 
competitive binding. 
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Figure 6.2: DNA dehybridization irreversibility. (a) Schematic depicting the released DNA 
behavior with and without complementary sequence. (b) Graph shows the amount of DNA 
released versus the temperature based on the released DNA fluorescence intensity with (red) and 
without (black) complementary sequence. 
The results of this experiment are shown in Figure 6.2. Here it can be seen that the fluorescent 
signal due to the released DNA agrees for the two release conditions within experimental error, 
and that the DNA dehybridization on the Au nanoshell surface is an essentially irreversible 
process. This dehybridization irreversibility is critical for biological applications, and must be the 
case for the released DNA to be delivered to proceed to mRNA binding, in the case of antisense 
oligonucleotide therapy. 
Two main factors contribute to the dehybrization irreversibility. First, rehybridization of the 
released ssDNA would require it to hybridize with the complementary sequences on the Au 
surface, a process well documented to be of low efficiency. 194 In addition, after dehybridization, 
the sense sequence on the nanoparticle surface may loop and bind non-specifically directly onto 
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the Au surface, preventing rehybridization. This effect would be likely for all metal surfaces with 
high affinity to DNA. It is worth noting that the presence of the SN3-complement in solution did 
not appreciably affect either the DNA melting temperature (around 35 °C) or the amount of DNA 
released. At low temperatures, however, the amount of DNA released in the presence of the 
excess SN3-complement sequence is slightly higher due to non-thermal DNA release, either due 
to nonthermal dehybridization or the presence of some nonspecifically bound ssDNA on the 
nanoparticle surface. 
6.3.2 Thermal Release o(ssDNA: 
dsDNA dehybridization is an essential process in all biological systems as well as many DNA-
based nanotechnology applications. The mechanism of dsDNA thermal dehybridization has been 
thoroughly studied195 • It has been shown that dsDNA attached to surfaces, in particular Au 
surfaces, behaves differently than free dsDNA in terms of melting temperature and phase 
transition. 196 
We first studied the thermal dehybridization of dsDNA attached to Au nanoshell surfaces. Gel 
electrophoresis has been used to determine the amount of ssDNA released, a process requiring 
no fluorescent labeling of the DNA. In the 3% agarose gel used in this work, the pore size is 
much smaller than the nanoshell diameter. Consequently, the nanoshells in the DNA/nanoshell 
suspension are trapped in the gel electrophoresis wells. Only free DNA will migrate through the 
gel matrix. Comparing the bands intensities of the released ssDNA from aliquots taken at 
different temperatures reveals the progression of the DNA release in the DNA/nanoshell sample, 
since the band intensity is proportional to the concentration of DNA. 
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Figure 6.3: Thermal (a) and light-assisted (b) release of ssDNA from dsDNA-coated nanoshells 
in solution. The melting curves for 20 base dsDNA attached to Au nanoshell surface are shown. 
Insets show the first derivatives of the melting curves, depicting the melting temperatures T m of 
each process. 
DNA melting curves, obtained by monitoring the UV fluorescence (from the DNA-associated 
dye Syber green) in the gel column as a function of solution-ambient temperature, are shown for 
thermal DNA dehybridization (Figure 6.3.a) and for light-induced DNA dehybridization (Figure 
6.3.b). The UV absorption intensity is directly proportional to the amount of DNA released. The 
maximum of the first derivative of these curves, corresponding to the temperature of maximum 
DNA release, is defined as the DNA melting temperature, T m· For both thermal and nonthermal 
DNA release, the derivative plots are shown as insets. The melting temperature of the 20 base 
dsDNA (SN4 with its thiolated complement) attached to Au nanoshells was experimentally 
determined to be 37 °C (Figure 6.3.a). The melting temperature of the same dsDNA sequence in 
solution, not confined to Au surface, is expected to be nominally 50 °C at 50 mM salt 
concentration (IDT DNA). Although the salt concentration on the nanoshell/DNA solution is 
likely to be somewhat lower than 50 mM due to ethanol precipitation of the DNA prior to 
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binding to the nanoshell surfaces, there is still clearly a significant decrease in the DNA melting 
temperature when DNA is bound to the Au surface relative to the anticipated solution phase T m· 
The same trend was consistent for all DNA sequences investigated in this study. It is interesting 
to note that DNA melting temperature depression for DNA bound to an Au surface is still a 
matter of debate: both increasing and decreasing T m for DNA on Au nanoparticles relative to the 
corresponding solution phase value have been reported. 196• 197 
Under the experimental conditions described above, the T m of the dsDNA sequence attached 
to Au nanoshell surfaces has shown a significant decrease. 196 Most likely, the high affinity of 
DNA to the Au surface is playing an essential role in the T m reduction. In solution, the T m 
depends solely on DNA strand length and base composition. However, when one strand of the 
duplex is attached to a surface, the T m may be affected by the influence of the surface on the 
duplex stability. Because of the high affinity of ssDNA to the Au surface, the single-stranded 
DNA form is more favorable than when in solution, which would result in a decrease in DNA 
melting temperature. 
6.3.3 Light-induced Release o(ssDNA: 
The DNA melting curve for light-assisted DNA dehybridization is shown in Figure 6.3.b, 
with the first derivative of the melting curve shown in the inset. Here the T m of the 20 base DNA 
sequence, the same sequence used in thermal dehybridization, is 27 °C. This corresponds closely 
to the ambient temperature of the DNA-nanoshell suspension. This lack of temperature increase 
corresponds to two possible mechanisms for DNA release. These are: [1] a nonequilibrium 
thermal mechanism, where the irradiated nanoparticle undergoes a strong and rapid temperature 
increase at its surface sufficient to melt the DNA but not sufficient to raise the ambient solution 
temperature, or [2] a nonthermal mechanism, such as charge transfer to the DNA adsorbate, 
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resulting in DNA dehybridization driven by Coulomb repulsion. Further experimentation would 
be needed to specifically identify which mechanism or mechanisms may be responsible for the 
DNA release. 
To examine this ambient-temperature light-induced dehybridization further, both thermal and 
light-assisted dehybridization experiments were performed on three other sequences (30, 50, and 
70 bases). Correspondingly, similar distinct decreases in the T m due to thermal dehybridization 
and to light-assisted dehybridization of dsDNA attached to nanoshells were observed (Figure 
6.4). For all sequences studied, light-assisted DNA dehybridization is observed to occur at 
essentially ambient temperature. While further studies are warranted to determine the specific 
light-induced release mechanism, the fact that release occurs at ambient temperature over a range 
of oligonucleotide lengths and compositions is extremely encouraging for gene therapy 
applications. The fact that laser-induced gene release can occur in a regime where the laser 
irradiation does not increase the ambient temperature indicates that this process may be useful 
for the safe release of oligonucleotides in cells without inadvertently compromising cell viability. 
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Figure 6.4: Comparison of the light-induced (green) versus thermal (red) dehybridization of 
dsDNA sequences of different lengths tethered to Au nanoshells. For all DNA sequences studied, 
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the light-assisted melting temperatures are lower than 30 °C which makes this system suitable for 
releasing ssDNA as long as 70 bases in biological applications. 
6.3.4 Surface coverage and percentage release: 
DNA surface coverage on nanoshells was determined using a previously reported protocol 
with minor modifications. 194 In this procedure, (i) the concentration of nanoshells is determined 
from the extinction spectra and Mie theory, (ii) the emission intensity of fluorescence-labeled 
DNA displaced from the nanoshell surface is measured, and (iii) the fluorescence intensity is 
correlated to the DNA concentration through a standard, previously determined curve. The 
number of molecules and the percentage of ssDNA released from the nanoshell surface can be 
determined by comparing the fluorescence intensity before and after thermal or light illuminated 
DNA release. 
The coverage of dsDNA molecules on Au nanoshells was determined to be 6400 dsDNA 
molecules/nanoshell which corresponds to 14.6 pmol/cm2• This coverage is consistent with 
previous results of oligonucleotide surface coverage on Au films (18.1 ±3 pmol/cm2). 194 Due to 
the 150 nm diameter size of the NS particle, its surface is more analogous to a gold film 
compared to a small gold nanoparticle. This observation is consistent with published results 
indicating that the packing density of oligonucleotides on the surface becomes analogous to 
packing densities on a gold film when a spherical gold nanoparticle substrate approaches 150 nm 
in diameter. 198• 199 The decrease in packing density determined for DNA on nanoshells relative 
to that reported for planar Au surfaces may be due to: [1] the use of dsDNA in our studies 
instead of ssDNA, and [2] a decreased salt concentration needed to prevent nanoshell 
aggregation, which reduces electrostatic repulsion between DNA chains and decreases overall 
packing density. 194 
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The percentage of DNA released was determined for the cases of both thermal and light-
induced DNA dehybridization. While ~90% of the ssDNA is released for thermal 
dehybridization, only ~50 % of the total available ssDNA is released for the light-induced 
process. The fact that these release percentages are so remarkably different provides strong 
support for a fundamental difference between the thermal and light-induced DNA 
dehybridization process. While it is not surprising that the thermal release process, conducted 
under equilibrium conditions, results in the greatest percentage of ssDNA released from the 
nanoshell surface, it raises significant further questions regarding the actual release mechanism 
or mechanisms involved in light-driven DNA release. It is also important to note that the number 
of ssDNA molecules released per nanoshell in the case of light-induced release (3169 
ssDNA/nanoshell) is considerably larger than the number of molecules released by the same 
process on nanorods (250 molecules/nanorod). 64 This possible dependence of yield on the 
aspect ratio of the nanoparticle also suggests that this process occurs under highly 
nonequilibrium conditions on the nanorods surface, or that a charge-transfer mechanism may be 
important in the release process. 
6.4 Conclusion: 
Both thermal and light-triggered dehybridization of dsDNA where one complementary strand 
was covalently bound to Au nanoshells was investigated. In contrast to dehybridized ssDNA in 
solution, dehybridization of dsDNA bound to an Au nanoparticle surface is shown to be 
essentially irreversible. The melting temperatures of dsDNA bound to nanoshell surfaces was 
assessed for both thermally-induced and resonant light-induced dehybridization. A large 
difference in T rn was observed for each process, and each process occurs at a T rn substantially 
lower than the corresponding melting temperature of the same oligonucleotide in solution. 
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The light-induced dehybridization of dsDNA bound to Au nanoshells appears to occur at the 
solution-ambient temperature for all dsDNA sequences and lengths studied. The coverage of 
dsDNA on Au nanoshell surfaces was quantified and shown to correspond closely to packing 
densities obtainable on planar Au films. By quantifying surface coverage of dsDNA, we were 
also able to determine the percentage of ssDNA released for both the thermal (~90%) and the 
light-induced (~50%) release process. These studies point to some very interesting and dramatic 
differences between thermal and light-induced processes on plasmon-resonant nanoparticle 
surfaces. Not only does this system provide a promising potential for light-controlled gene 
release for gene therapy, it also provides a new and exciting context where the rich chemical 
physics of substrate-adsorbate interactions may prove relevant to our understanding of light-
actuating nanoparticle complexes. 
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Chapter 7: Visualizing Light-triggered Release of Molecules Inside 
Living Cells 
7.1 Introduction: 
7.1.1 Biomedical Applications o(Plasmonic Nanoparticles: 
Strategies for the directed release of controlled quantities of molecules inside living cells are in 
high demand for drug delivery,200 gene therapy,201 • 202 and tissue engineering.203• 204 The release 
mechanisms of most delivery vectors depend on processes such as diffusion, dissolution, 
chemical and enzymatic reactions, or changes in various environmental factors such as 
temperature, pH, solvent, and ionic concentrations.201 ' 205-208 For example, transfection reagents 
such as polyethylenimine act as a proton sponges following endocytosis, absorbing protons in the 
low-pH environment of the endosome, causing it to swell and eventually rupture, facilitating 
gene delivery.209 This type of environmental control of molecular release varies with cellular 
location and cell type, and can result in unpredictable release. A physical release mechanism 
that does not rely on the specific chemical properties of the cellular environment would be highly 
useful and more easily generalizable to various cell types.210 Light-induced release is a 
particularly attractive option: the high spatial and temporal control that lasers provide would be 
highly useful for initiating and following intracellular processes dynamically, at the single cell 
level. 211-217 
Plasmonic nanoparticles, metal-based nanostructures supporting collective electronic 
oscillations, are highly promising potential candidates for facilitating controlled light-triggered 
release, due to their large optical cross sections, their geometrically-tunable optical resonances218• 
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219 and their strong photothermal response.220• 221 Because of their large cross sections and 
extremely low quantum yield, metallic nanoparticles convert optical energy to thermal energy 
with high efficiency upon resonant optical illumination.27' 222 Resonant optical illumination of 
the nanoparticle triggers the controlled dehybridization and release of DNA molecules adsorbed 
onto the nanoparticle surface. 215• 217 Gold nanoparticles are also biocompatible, easy to fabricate, 
and can be functionalized with a wide variety of host-carrier molecules capable of noncovalent 
accommodation of guest molecules. 205• 217 
In the previous chapter I described light-induced dehybridization of double-stranded DNA 
(dsDNA) attached to Au nanoshells.217 Nanoshells with plasmon resonance wavelength at 800 
nm were coated with dsDNA, where one strand of the DNA had a thiol moiety on its 5' end, 
facilitating covalent attachment to the nanoshell surface by a Au-thiol bond. The complement 
DNA sequence was nonthiolated, and therefore bound only to its complementary DNA sequence 
and not to the nanoparticle surface. Upon illumination with NIR light at the nanoshell plasmon 
resonance wavelength, the dsDNA was dehybridized, releasing the antisense sequence. This 
process is highly efficient, resulting in the dehybridization and release of nominally 50% of the 
DNA from the complexes upon illumination, with no apparent temperature increase in the 
solution ambient. DNA antisense therapy has been explored extensively as a class of gene 
therapy and has highly promising potential to provide safe and effective treatments for a 
multitude of diseases and genetic disorders. 223 
Here we show that, in addition to light-controlled release of DNA, the nanoshell-dsDNA 
complex serves as an effective host and light-triggered release vector for other types of 
molecules. Many types of guest molecules can associate with dsDNA, either by intercalating 
between adjacent base pairs or by binding in either the major or minor groove of the DNA 
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double helix. 224 The driving forces for association can include 1t-stacking, hydrogen bonding, 
van der Waals forces, hydrophobic and polar interactions, and electrostatic attractions; therefore, 
dsDNA can host a large variety of guest molecules via noncovalent bonds.224• 225 
7.1.2 DAPI (4'.6-diamidino-2-phenylindole) 
DAPI (4',6-diamidino-2-phenylindole), a water soluble blue fluorescent dye that binds 
reversibly with dsDNA (Figure 84) is the molecule we chose to deliver, to demonstrate and 
clearly visualize the light-induced intracellular release. DAPI was chosen because of its bright 
fluorescent properties, stability and negligible toxicity.226 DAPI binds preferentially to the minor 
grooves of dsDNA: its association with DNA causes a large increase in its quantum yield. 226-230 
The selectivity of DAPI to dsDNA makes it a frequently used, standard stain for cell nuclei in 
fluorescence microscopy. 229• 230 
A schematic of the light-triggered molecular release is shown in Figure 7.1. Initially, 
nanoshell-dsDNA complexes were loaded with DAPI by incubation of DAPI with the nanoshell-
dsDNA complexes. Next, the nanoshell-dsDNA-DAPI complexes were incubated with H1299 
lung cancer cells, where intracellular uptake was verified using both dark-field and bright-field 
microscopy. Upon illumination with an 800 nm CW laser, corresponding to the peak resonant 
wavelength of the nanoshell complexes, the DAPI molecules were released from the nanoshell 
complexes. Subsequent to release, the DAPI diffused through the cytoplasm and into the cell 
nucleus, where it preferentially bound and stained the nuclear DNA. To the best of our 
knowledge, this is the first light-controlled delivery system that can be tailored to release 
quantifiable amounts of nonbiological molecules, within living cells by remote means, on 
demand. 
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Figure 7.1 Light-induced DAPI release. (a) Schematic diagram of the light-induced DAPI 
release and diffusion inside the cell. (b) Fluorescence emission of (i) DAPI only, (ii) DAPI with 
ssDNA, and (iii) DAPI with dsDNA. 
7.2 Results and Discussion: 
7.2.1 DAPI Fluorescence Emission: 
The DAPI fluorescence emission intensity drastically increases as a result of DAPI molecules 
binding to DNA (Figure 7.l.b). As an isolated molecule, DAPI has a low quantum yield (Figure 
7.l.b, i), 227 however, when DAPI is attached to single stranded DNA (ssDNA) (Figure 7.l.b, ii), 
a weak electrostatic attraction binds the cationic DAPI molecules to the negatively charged 
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phosphate backbone of the DNA, resulting in a slight increase in its fluorescence intensity. 227 
When the DAPI molecules bind to the minor grooves ofthe dsDNA (Figure 7.l.b, iii),227• 230 the 
increased rigidity and stabilization significantly increases its quantum yield.226 DAPI binding to 
the dsDNA also displaces H20 molecules initially solvating the DNA oligomers, significantly 
reducing intermolecular proton transfer between H20 and DAPI, resulting in an additional 
increase ofDAPI fluorescence intensity.227• 228• 231 
The specific base-pair composition of the dsDNA plays an important role in determining the 
number of DAPI molecules that will bind to the dsDNA.232 Previous studies have shown that 
DAPI preferentially binds to regions rich with adenine (A) and thymine (T) nucleotide bases 
because DAPI forms hydrogen bonds with A-T bases pairs.230 The DAPI molecule is 14-15 A 
long, corresponding to an overlap of three base pairs.227-229' 232 In our experiments, since it is 
desirable to bind as many DAPI molecules as possible to improve the staining of the nucleus 
after light-induced release, we designed a 26-base pair sequence with multiple A-T -rich regions 
with segments of three or more consecutive A-T base pairs to specifically enhance DAPI 
loading. 
7.2.2 Nanoshell Cell Uptake: 
To use this light-triggerable complex for molecular release in live cells, the complex must first 
be effectively taken up by the cells of interest. To facilitate cell uptake, the nanoshell-dsDNA-
DAPI complexes were incubated with Hl299 lung cancer cells in serum containing cell culture 
medium for 1 hour. After incubation, the cells were fixed and internalization of the nanoshell-
dsDNA-DAPI complexes was imaged using both dark field (Figure 7.2.a-b) and bright field 
(Figure 7.2.c) microscopy. Nanoshells in this size range both absorb and scatter light: their 
strong scattering cross section enables them to be easily visualized by optical microscopy. In 
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Figure 7.2.a, a H1299 cell with its cell membrane marked by the green fluorescence dye Alexa 
Fluor 488 WGA (wheat germ agglutinin) is shown. Internalized nanoshells are easily seen as 
diffraction-limited bright spots in this image. As a control, cells not incubated with the 
nanoshell-dsDNA-DAPI complexes showed no observable bright spots when imaged in the same 
manner (Figure 7.2.b). 
Figure 7.2 Nanoshell-dsDNA-DAPI Cell uptake. Dark field/epifluorescence images of (a) 
H1299lung cancer cells incubated with nanoshell-dsDNA-DAPI complexes, (b) nonincubated 
cells (control). (c) Bright field image of middle slice ofH1299lung cancer cells incubated with 
nanoshell-dsDNA-DAPI complex. 
Because the dark-field images are two-dimensional, these images alone do not give clear 
evidence whether the nanoshell complexes have been endocytosed, or are merely adsorbed onto 
the outer membrane of the cell. Bright-field imaging was used to further investigate cellular 
uptake. Obtaining images at varying depths of field within an individual cell allows us to clearly 
visualize in three dimensions the nanoshell distribution within the cell. Figure 7 .2.c is a slice 
from the middle of the cell showing clear diffraction-limited dark spots corresponding to 
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nanoshell complexes, verifying that the nanoparticles are internalized within the cell. A video 
sequence of two-dimensional projections obtained as the depth of field is scanned through the 
cell resolves the 3D distribution of nanoshell. Internalization of nanoshells is in agreement with 
observations by Ochsenkiihn et a/, who used TEM sections of NIH-3T3 fibroblast cells to 
confirm nanoshell uptake. 233 
At first thought, it is surprising that the nanoshell-dsDNA-DAPI complex is internalized into 
cells because the negatively-charged phosphate backbone on the DNA should experience 
electrostatic repulsions with the negatively-charged cell membrane. 234 However, previous 
studies by Chithrani et a/ and Giljohann et a/ suggest that Au nanoparticles functionalized both 
with and without DNA adsorb extracellular serum proteins from the cell culture media.234• 235 
The adsorbed extracellular proteins then interact with the cell membrane and facilitate cellular 
uptake in an adsorptive endocytosis pathway. Conversely, recent studies by Ochsenkiihn eta/ 
show that nanoshell uptake increases in the absence of extracellular proteins, suggesting the 
possibility of a passive, nonendocytotic uptake mechanism.233 While in our studies nanoshell 
complex uptake is clearly visualizable in H1299 cells, the precise uptake mechanism is not 
clearly identifiable, and is likely to depend on a variety of factors including cell type, 
functionalization of the nanoparticle, and incubation conditions. 
7.2.3 Intracellular Light-Induced DAPI Release: 
To investigate intracellular light-induced molecular release, the H1299 cells incubated with 
nanoshell-dsDNA-DAPI complexes were illuminated with a NIR CW laser (1 W/cm2, 800 nm) 
for 5 minutes. This irradiation time and laser power level were determined from previous 
experiments,217 which demonstrated after 5 minutes oflaser irradiation no additional 
dehybridization of the DNA occurred. This laser power and time allow the DAPI to be released 
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while minimizing laser exposure to the Hl299 cells. After laser irradiation, samples were placed 
in an incubator for one hour to allow time for released DAPI molecules to diffuse to the nucleus. 
Next, the nuclei of the cells were isolated by lysing the cell membrane (see supplemental 
information) and the DAPI fluorescence intensity was quantified by flow cytometry. Nuclei 
isolation is necessary to ensure that flow cytometry only measures fluorescence from DAPI 
molecules bound to genomic DNA in the nucleus and does not measure fluorescence from DAPI 
molecules in the cytoplasm. 
Evidence of DAPI release is shown by the normalized flow cytometry histograms of DAPI 
fluorescence intensity versus number of nuclei from H1299 cells incubated with nanoshell-
dsDNA-DAPI before and after laser treatment (Figure 7.3). After laser treatment, the 
fluorescence intensity of the nuclei increased, demonstrating that DAPI molecules were released 
from the nanoshells, diffused through the cytoplasm and into the cell nuclei, binding with the 
genomic DNA. Prior to laser irradiation, some DAPI fluorescence is observed within the cells 
(Figure 7.3.c, left) and measured by flow cytometry (Figure 7.3.a-b, before laser). This DAPI 
fluorescence signal originates from both excess DAPI molecules present in the sample and DAPI 
molecules which were non-controllably released from the complexes during the incubation and 
prior to laser irradiation. 
The bar graph depicts the mean DAPI fluorescence intensity ± SEM (standard error of the 
mean) increase from before laser (59.7±0.21) to after laser (79.8±0.33) (Fig. 3a). A -33% 
increase in fluorescence intensity. An unpaired t-test of the two means was performed at a 95% 
confidence level, which resulted in a two-tailed p value of p < 0.0001, which is statistically 
significant. This observed increase in DAPI fluorescence after laser treatment (-33%) 
demonstrates that the nanoshell-dsDNA complex effectively released its guest molecules from 
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the dsDNA host carriers inside the cells. Epifluorescence images of Hl299 cells incubated with 
nanoshell-dsDNA-DAPI before (Figure3c, left) and after (Figure 7.3.c, right) laser treatment 
visually show the increase in DAPI fluorescence intensity. The cell membrane is marked by the 
green dye, Alexa-Fluor 488 wheat germ agglutinin. 
The plasmon resonant illumination of the nanoshells is crucial for DAPI release into the cells. 
To test this hypothesis, a control experiment consisting ofH1299 cells incubated with DAPI only 
(no nanoshells) was conducted (Figure 7.3.b). The cells were irradiated with the NIR laser under 
conditions identical to the previous experiment. The mean DAPI fluorescence intensity ± SEM 
did not significantly increase after laser irradiation (237±0.86 to 239 ± 0.95, p = 0.1188), 
indicating that DAPI release does not occur without the presence of the nanoshell-dsDNA 
complex. It is important to note that the mean fluorescence intensity is higher for the control 
(Figure 7.3.b) compared to the nanoshell-dsDNA-DAPI sample (Figure 7.3.a) due to multiple 
washings of the nanoshell-dsDNA-DAPI sample. 
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Figure 7.3 Light-induced DAPI release. (a-b) Flow cytometry histograms ofDAPI Fluorescence 
(Ex: 355nm/Em: 460 nm) versus number of isolated nuclei from H1299 cells incubated with a) 
nanoshell-dsDNA-DAPI and b) DAPI (control). Negative control (gray), treated cells without 
laser irradiation (blue) and treated cells with laser irradiation (red). Bar graphs display the mean 
DAPI fluorescence intensity± SEM before and after laser irradiation. (c) Bpi fluorescence images 
ofH1299 cells incubated with nanoshell-dsDNA-DAPI (left) before and (right) after laser 
treatment. The cell membrane is marked by the green dye, Alexa-Fluor 488. 
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The shape of the flow cytometry histograms for both before laser and after laser are consistent 
with nuclei stained with DAPI. DAPI is routinely used to study the cell cycle because it binds to 
DNA stoichiometrically. Looking at the before laser histogram in Figure 7.3.a as an example, 
the tallest peak ( ~40) originates from nuclei with two sets of chromosomes. This peak is the 
tallest because in a typical cell cycle, a cell spends the longest portion of time with two sets of 
chromosomes; therefore, the probability of a cell having two sets of chromosomes is the highest. 
The second, smaller peak ( ~80), double the fluorescence intensity of the tallest peak, indicates 
nuclei which have exactly double the amount of DNA, four sets of chromosomes, and are ready 
to enter mitosis and divide. The nuclei with fluorescence intensities in between these two peaks 
indicate cells which are currently synthesizing DNA prior to mitosis. The negative control 
histogram (gray) has a single peak because in the absence of DAPI every nuclei essentially 
fluoresces identically resulting in a signal which is attributed to autofluorescence (background). 
7.2.4 Cytotoxicity Study: 
To ensure that this method for light-triggered intracellular molecular release would be useful 
for biomedical applications, such as drug delivery, a cytotoxicity assay was performed to 
investigate both the effects of nanoshells and laser irradiation on cell viability. Propidium iodide 
(PI) was chosen as a marker to distinguish viable from non-viable cells, because it is a 
membrane-impermeable dye which is excluded from viable healthy cells.236 When a cell 
membrane is damaged, PI enters the cell, stains the dsDNA in the nuclei and emits red 
fluorescence; however, undamaged cells will not fluoresce. Flow cytometry was used to observe 
changes in PI fluorescence intensity for a large sample size of 30,000 cells. The negative control 
(Figure 7.4.a) consisted of cells which were not incubated with nanoshell-dsDNA-DAPI and did 
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not undergo laser treatment. The fluorescence observed in Figure 4a is attributed to 
autofluorescence and PI staining caused by apoptotic and necrotic cells already present in the 
experiment, with damaged membranes. The nanoshell-dsDNA-DAPI complexes were then 
incubated with H1299 cells for 12 hours. Following incubation, the cells were divided into two 
samples: cells not treated with the laser (Figure 7.4.b) and cells treated with the laser for 10 
minutes (Figure 7.4.c). Figure 7.4.b shows no significant increase in PI fluorescence intensity, 
demonstrating that nanoshell-dsDNA-DAPI complexes are not cytotoxic under the experimental 
conditions of the study. 
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Figure 7.4 Flow cytometry cytotoxicity assay. All plots are side-scattered light (SS) versus 
Propidium Iodide (PI) intensity. (a) Negative control: H1299 cells not incubated with nanoshell-
dsDNA-DAPI and no laser treatment. Cells incubated with nanoshell-dsDNA-DAPI for 12 
hours: (b) without laser treatment and (c) with laser treatment. (d) Positive Control: Cells were 
treated with 0.1 %Citrate/0.1% Triton, which permeates the cell membrane, allowing PI to stain 
the dsDNA in the nucleus. 
More interestingly, cells incubated with nanoshell-dsDNA-DAPI complexes and irradiated 
with the laser for 10 minutes also show no significant increase in PI fluorescence intensity. This 
demonstrates that the light-triggered release procedure did not adversely affect the cells. 
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Considering nanoshells are well-known for their use in photothermal therapy, this result may be 
surprising; however, the illumination conditions for this experiment (1 W/cm2, 5 minutes) were 
significantly below those used for photothermal induction of cell death in cell culture (4W/cm2, 
4-6 minutes).221 Figure 7.4.d represents a positive control sample of cells treated with 0.1% 
Citrate/0.1% Triton solution, which permeates the cell membrane, allowing PI to enter the cell 
and stain the nucleus, resulting in a large increase in PI fluorescence intensity. 
7.3 Conclusion: 
In conclusion, nanoshells functionalized with dsDNA were successfully used to transport 
DAPI molecules into living cells. Successful uptake of nanoshells into H1299 cells was 
achieved. DAPI molecules, initially bound to the dsDNA on the NS surface, are released due to 
the illumination of the nanoshell-dsDNA-DAPI complex with the appropriate NIR light. DAPI 
molecules initially released in the cell cytoplasm diffuse into the cell nucleus and bind to the 
genomic DNA of the cell. The staining of the cell nucleus with the released DAPI was quantified 
using flow cytometry. A cytotoxicity assay demonstrated that nanoshell uptake is nontoxic and 
that laser irradiation of nanoshell-laden cells under the conditions where DAPI release occurs 
does not induce cell death. 
This nanoshell-dsDNA system could be extended to a multitude of other guest molecules that 
associate with the host dsDNA carrier including small organic fluorophores,225 steroid 
hormones,237 and therapeutic molecules.224' 225 ' 237 For example, the quest to find dsDNA 
intercalators that inhibit the uncontrollable replication of tumor cells comprises an entire field of 
cancer research. Currently, there are more than 130 FDA approved anti-cancer drugs that 
specifically target DNA.238 For in vivo clinical applications, however, before the DNA 
intercalator can reach the genomic DNA, it must overcome several hurdles, such as metabolic 
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pathways and cytoplasmic and nuclear membranes. As a result, the failure of DNA therapies to 
offer successful clinical treatments is primarily due a lack of viable delivery methods rather than 
effectiveness of the DNA intercalator to treat cancer.224 This nanoshell-dsDNA delivery vector 
preserves the guest molecule by minimizing non-desired interactions with other molecules and it 
provides light-triggered release with controllable delivery. 
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Chapter 7: Conclusions and perspectives 
In this thesis, Gold nanoshells were used as SERS active substrates to investigate spectral 
properties of DNA molecules. The SERS spectra obtained from untreated DNA were very non-
reproducible and varies based on DNA base composition and state (single or double stranded). 
After DNA thermal treatment, the SERS DNA spectral quality and reproducibility were greatly 
enhanced. All DNA spectra acquired were very identical and dominated by the adenine modes 
regardless of base composition, DNA length or state. After thermal treatment DNA molecules 
are more rigid and adopt a more linear structure causing a great improvement in surface 
coverage. As a result, the reproducibility of SERS spectra is tremendously improved. 
The high reproducibility of DNA spectra allowed the detection of DNA perturbation caused 
by the binding of small molecules to DNA. The binding of small molecules to DNA strands 
initiates kinks and bends in the DNA strands causing a significant decrease in the spectral 
reproducibility. The detection of the real time binding of cisplatin, commonly used 
chemotherapy, to DNA was achieved using SERS. The discrimination between cisplatin and 
transplatin (structurally similar to cisplatin but does not bind to DNA) interactions with DNA 
was very obvious. The DNA SERS system can be further developed to be used for screening 
potential new chemotherapeutic molecules and assess their binding to DNA. 
A label-free DNA detection system was developed using SERS. The new system is based on 
the adenine SERS spectral dominance. When the capture strand is adenine-free or adenine 
substituted, the SERS of the capture strands is missing all adenine features. The target binding 
event is detected by the appearance of a strong peak from adenine bases on the target sequence. 
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It turns out that the intensity of the adenine peak is directly related to the DNA target 
concentration which makes the developed system not only label-free but also self calibrated. 
SERS was also used to detect and identify DNA base chemical modifications on DNA strands. 
DNA base modifications have been proven to be related to certain diseases such as cancer as 
well as playing main role in epigenetic. Four different base modifications: adenine methylation, 
cytosine methylation and hydroxymethylation and guanine oxidation were all detected using 
SERS. Each base modification causes the appearance or disappearance of certain SERS features 
unique for that modification, which make the system reliable for detecting single or multiple 
base modifications. The SERS detection is very straightforward and does not require any sample 
preparation eliminating possible chemical modifications caused by interaction of DNA with 
various chemicals. SERS detection enabled discrimination between cytosine methylation and 
hydroxymethylation on the DNA strands investigated. The discriminations between these two 
bases is considered particularly challenging in the field of epigenetic due to their chemical and 
structural similarity and complexity of detection using common methods . The described method 
is the first attempt in using SERS in epigenetic research. The simplicity of the SERS detection 
may introduce SERS-bases DNA chemical modifications screening as routine in clinical 
diagnosis. 
On the second part of this thesis, Au nanoshells were used as non-viral, controllable drug 
delivery systems. Au nanoshells can be promising triggered non-viral drug delivery systems 
owing to their exceptional photothermal property. Upon light illumination, Au annoshells 
efficiently convert part of that light into heat which is used to dehybridize double stranded DNA 
attached to the nanoshell surface. Single stranded DNA can then be delivered for antisense gene 
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therapy or small DNA interculators for conventional therapy s well as in vivo intracellular 
imaging. 
Investigated cells can uptake Au nanoshells at very high efficiency and the DNA can be 
dehybridized and delivered at temperature lower than 3 7°C upon light irradiation which makes 
the system ideal for intracellular drug delivery and controlled release of ssDNA and small 
molecules. DAPI molecules, typically used to stain cell nuclei, were bound to the dsDNA 
initially tethered to the Au annoshells. After incubation with H1299 cancer cells and upon light 
irradiation, Au nanoshells were able to release their DAPI payloads. DAPI, then, diffused on the 
cytoplasm, crossed the nuclear membrane and stained the nuclear DNA. Brighter cellular nuclei 
were seen after Au NS/DNA/DAPI uptake and DAPI release. The Au nanoshell system 
efficiently holds the DAPI payload, carries it into the cell cytoplasm and releases it upon light 
illumination. The system can be further developed to span other potential therapeutic agents such 
as siRNA, dsDNA , etc. 
The field of plasmonic has been largely expending bringing new applications that affected 
many areas such as medicine, sensing, and energy. The applications of plasmonic on medicine 
are particularly essential as I believe the fight against diseases is the main goal of science. The 
plasmonic nanostructures can combine the efficiency of delivery and the control of release to 
form ideal drug delivery systems. Finally, I hope that this work will be a contribution to reach 
our global goal to improve human health and life in general. 
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Appendix: Publications and Patents 
PUBLICATIONS 
• Yu Zhang, Aoune Barhoumi, J. Britt Lassiter, Naomi J. Halas, "Orientation-Preserving 
Transfer and Directional Light Scattering from Individual Light-Bending 
Nanoparticles" Nano Lett. ASAP. 
• Aoune Barhoumi, Naomi Halas, "Label-Free detection of DNA hybridization Using 
Surface Enhanced Raman Spectroscopy" J. Am. Chern. Soc. 2010, 132, 12792-12793. 
• Ryan Hushka, Oara newman, Aoune Barhoumi, and Naomi Halas "Visualizing Light-
Triggered Release ofMolecules Inside Living Cells" Nano Lett. 2010, 10, 4117-22. 
• Aoune Barhoumi, Ryan M. Huschka, Rizia Bardhan, Mark W. Knight, Naomi 
Halas, "Light-Induced Release of DNA from Plasmon-Resonant Nanoparticles: Towards 
Light-Controlled Gene Therapy" Chern. Phys. Lett. 2009, 482, 171-179. COVER 
ARTICLE 
• Carly S. Levin, Janardan Kundu, Aoune Barhoumi, Naomi Halas "Nanoshell-Based 
Substrates for Biomolecular Spectroscopic detection" Analyst 2009, 134, 1745-1750. 
• Janardan Kundu*, Oara Neumann*, Benjamin Janesko, Dongmao Zhang, Surbhi Lal, 
Aoune Barhoumi, Gustavo Scuseria, Naomi J. Halas "Adenine- and Adenosine 
Monophosphate (AMP)- Gold Binding Interactions Studied by Surface Enhanced Raman 
and Infrared Spectroscopies" J. Phys. Chern. C 2009, 113, 14390-14397. 
• Dongmao Zhang, Hui Wang, Oara Neumann, Aoune Barhoumi, Michael Perham, 
Jeffrey Hartgerink, Pemilla Wittung-Stafshede, Naomi J.Halas "Gold Nanoparticles can 
Induce the Formation of Protein-Based Aggregates at Physiological pH" Nano 
Lett. 2009, 9, 666-671. 
• Aoune Barhoumi, Dongmao Zhang, Felicia Tam, Naomi Halas "Surface-Enhanced 
Raman Spectroscopy of DNA" J. Am. Chern. Soc. 2008, 130, 5523-5529. 
• Aoune Barhoumi, Dongmao Zhang, Naomi Halas, "Correlation of Molecular 
Orientation and Packing Density in a dsDNA Self-Assembled Monolayer Observable 
with Surface-Enhanced Raman Spectroscopy" J. Am. Chern. Soc. 2008, 130, 14040-
14041. 
PATENTS 
• Aoune Barhoumi, Dongmao Zhang and Naomi Halas, "Composition for Targeted Drug 
Delivery and Controlled Release" United States Patent, 20100040549. 
• Aoune Barhoumi, Dongmao Zhang and Naomi Halas, "Device and Method for Label-
free Detection of DNA Hybridization" Filed on 08/16/2010. 
• Aoune Barhoumi, Ryan hushka, Oara Newman, and Naomi Halas "Triggered-release of 
DNA absorbed and/or intercalated from nanoparticles" Filed on 09/15/2010. 
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